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Abstract 
“The Thiopyran Route to Polypropionates” is a synthetic strategy that involves 
the stepwise aldol reactions of 6 and 7a to rapidly access stereochemically complex 
tetrapropionate 8 and hexapropionate synthons 72 or 73. Coupling racemic 7a with any 
of the four enantioenriched diastereomers 8 with kinetic resolution (KR) is possible 
with rational design of the  reaction using the 'multiplicativity' rule. Thus, any of two of 
the eight possible aldol adducts, 72 or 73, are selectively available from the same 
reactants. 
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The research in this thesis describes the effort to explore the scope and 
limitations of the above paradigm to design aldol reactions with KR. The synthesis of a 
variety of 'designed' aldehydes (7b-h), with an ethylene ketal, dithiolane, or dithiane 
 vi 
group at the β-position, and stereoselectivities of their reactions with boron and titanium 
"ate" enolates of 8ss (R = MOM or TES) are described. Each of the aldehydes 7b-h has 
one or two structural feature(s) different from aldehyde 7a.  
The reactions of boron enolates of (±)-8ss (R = MOM or TES) with aldehydes 
(±)-7b-g are highly anti-selective and proceeded with high mutual kinetic 
enantioselection (MKE) and produce one of the eight possible adducts, (±)-72b-g, with 
high selectivity. For reactions of racemic reactants, the MKE is the ratio of rate 
constants for reaction of a like versus unlike combination of reactant enantiomers. The 
MKE is simply determined by the ratio of product diastereomers. The reactions of 
titanium "ate" enolates of (±)-8ss (R = MOM or TES) with aldehydes (±)-7b-g are 
mostly syn-selective and proceed with moderate to good MKE producing (±)-73b-g but 
with lower selectivity compared to the boron enolates.  
In principle, the MKE determined for a reaction of racemic reactants will be 
equal to the selectivity constant (s) in a kinetic resolution (KR) when one of the 
reactants is enantiopure. Comparison of the results of current study with those reported 
for the boron and titanium "ate" mediated aldol reactions of aldehyde 7a shows that the 
aldol reactions of suitable enolates of enantioenriched 8 with aldehydes (+)-7b-g will 
occur with synthetically useful KR selectivity. As expected, reactions of (-)-8ss 
(R=MOM) with (±)-7f via the boron and titanium "ate" enolates produce enantiopure 
adducts with the stereoselectivity commensurate with the MKE observed using racemic 
reactants. 
 
 
 vii 
Some of the new aldol adducts accessed via coupling of enolate of 8 with new 
aldehydes 7b-g have decreased symmetry because of the presence of different ketal 
protecting groups. This structural feature makes them potentially useful for future 
synthetic application. 
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α observed optical rotation in degrees 
[α]D specific rotation at the sodium D line (expressed without units; 
implied actual units are: (deg·mL)/(g·dm)) 
Ac acetyl 
AcOH acetic acid 
ap apparent (NMR signal) 
aq aqueous 
Bn benzyl 
br broad (description of a spectral signal) 
n-BuLi n-butyllithium 
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CI chemical ionization (in mass spectrometry) 
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E and Z configurational descriptors for alkenes.  E denotes that the 
substituents of highest CIP (Cahn-Ingold-Prelog) priority at each end 
 xiii 
of the double bond are on opposite sides.  If the pertinent substituents 
are on the same side, the descriptor is Z. 
Et3N triethylamine 
EtOAc ethyl acetate 
FCC flash column chromatography 
h hour(s) 
HF hydrofluoric acid 
1H NMR proton nuclear magnetic resonance 
HRMS high resolution mass spectrometry 
IBX                      2-Iodoxybenzoic acid 
KR                       kinetic resolution 
like  stereodescriptor denoting those stereoisomers of a set whereby two 
designated stereogenic centers are R and S or vice/versa 
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MHz megahertz 
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PTLC preparative thin layer chromatography 
R and S absolute stereochemical configuration descriptors in the CIP (Cahn-
Ingold-Prelog) system 
rt room temperature 
sat saturated 
syn synperiplanar 
TES                      triethylsilyl 
TESCl                  triethylsilyl chloride 
THF tetrahydrofuran 
p-TsOH p-toluenesulfonic acid  
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1.  INTRODUCTION 
1.1. Polypropionates 
     Over the past 50 years, polyketide natural products have attracted many 
researchers. These natural products have been the subject of many reviews in chemistry 
and biochemistry and have provided the opportunity to conduct interdisciplinary 
research.1, 2 Polypropionates are a class of polyketides that include a structural motif 
consisting of alternating stereogenic centers bearing methyl and hydroxyl functionalities 
(Figure 1).3 Polypropionate synthesis in vivo proceeds through the reaction of coenzyme 
A activated monomers catalyzed by the polyketide synthase system (PKS).4 
OH∗
∗
∗
∗
OOO
n = integer
n
 
Figure 1. General structural motif of polypropionates (*= stereogenic center). 
     Numerous polypropionate metabolites have been isolated from marine 
organisms, with mollusks being the most common source.5 Many polypropionate natural 
products have valuable therapeutic properties such as anticancer, antifungal and 
antibiotic.6 Some interesting examples of polypropionate natural products are shown 
below (Figure 2). Due to their biological activity, the synthesis of polypropionates has 
attracted great interest leading to development of many successful synthetic methods. 
Despite these successes, general methods are lacking and access to a single 
diastereoisomer of a polypropionate becomes increasingly challenging as the number of 
2 
  
carbons in the chain increases. Consequently, there is continuing need for new synthetic 
approachs.7 
dolabriferol
 dihydrosiphonarin A R1 = Me; R2 = β-OH
 dihydrosiphonarin B R1 = Et;  R2 = β-OH
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OO OH
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O
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O
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OR1
O OH
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R2
O
1
2
3
4
5
 
Figure 2. Examples of polypropionate natural products. 
In the past, numerous methodologies were developed for polypropionate synthesis 
including Claisen rearrangements,8 iodocarbonylations,9 allenylmetal additions,10 crotyl 
metal additions,11 Diels-Alder cycloadditions,12 and metal mediated aldol reactions with 
those using titanium,13 tin13 or  boron13, 14 enolates being the most commonly employed. 
For example, the total synthesis of polypropionates anhyroserricornin,15 amphotericin B,16 
and baconipyrone C17 using aldol reactions have been reported.18 
1.2. The thiopyran route to polypropionate 
1.2.1.  Overview 
  The thiopyran route to polypropionates is a well developed strategy for 
polypropionate synthesis developed by the Ward group.19 This strategy permits the rapid 
3 
  
assembly of stereochemically complex polypropionate motifs from common precursors. 
One aspect of this approach concerns the synthesis of hexapropionate synthons 13. 
Retrosynthetic disconnection of the carboxyl group from a prototypical hexapropionate 
13 and oxidation state adjustment leads to trione 12 (Scheme 1). Trione 12 can be 
accessed by aldol couplings of 8 and 9. Three routes are possible depending on the 
sequence of the aldol couplings. The Ward group has been developing this strategy 
employing thiopyran precursors 6 and 7a as reagents synthetically equivalent to 8 and 9. 
The stereocontrol of the aldol couplings of 6 and 7a is quite versatile and 11 of 20 
possible diastereomers of 11 have been selectively obtained by our group in 2-4 steps.19 
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Scheme 1. Ward’s strategy for polypropionates synthesis. 
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1.2.2. First aldol reaction: the tetrapropionate synthon 
Each of the four possible diastereomers of the tetrapropionate synthon 8 are 
available via diastereoselective and enantioselective aldol reactions of the common 
starting materials 6 and 7a (Scheme 2).20 The aldol reactions of enolates of tetrahydro-
4H-thiopyran-4-one 15 with chiral aldehydes (±)-7a or (S)-7a are highly 
diastereoselective and give  different aldol adducts depending on the reaction conditions. 
For example, reaction of 15 and (±)-7a gives the racemic diastereomers 8as, 8ss and 8sa 
stereoselectively when MeLi, TiCl4 and MgBr2, respectively, are employed as mediators 
5 
  
(Scheme 2). The fourth diastereomer, 8aa, can be obtained from 8sa by imidazole-
catalyzed isomerisation.21 The aldol reaction of tetrahydro-4H-thiopyran-4-one 6 with 
racemic aldehyde (±)-7a in the presence of 5-[(2S)-pyrrolidine-2-yl]-1H-tetrazole (S)-14 
22
 proceeds with dynamic kinetic resolution to give enantiomerically pure 8as in excellent 
yield without chromotography.7 Isomerization of 8as provides a viable route to 
enantiopure 8ss. Highly enantioenriched 8sa is obtained by MgBr2 mediated reaction of 
15 with (S)-7a.23,24 Enantioenriched 8aa is obtained by isomerization of enantioenriched 
8sa.23 
Scheme 2. Synthesis of the four racemic and enantiopure diastereomers of aldol adduct 8. 
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1.2.3. Second aldol reaction : the hexapropionate synthon 
           The hexapropionate synthons 11 are prepared by the highly stereoselective aldol 
couplings of 7a with 8 (Scheme 1). Depending on the enolate mediator (titanium or 
boron) and the status of OH group (i.e., protected or not), each of the diastereomers of 
6 
  
enantioenriched 8 can be coupled with (±)-7a to give any of 3 diastereomers of 11a or 
11b or 11c  selectively (Scheme 3). Thus, by subjecting each of the four diastereomers of 
8 to the three different reaction conditions, 11 of 20 possible diastereomers of 11 can be 
selectively obtained from 6 and 7a in 2-4 steps.23,25  
Scheme 3. Summary of synthesis of the 3 diastereomers of bisaldol adduct 11 via KR. 
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 Each of the reactions in Scheme 3 can give up to eight aldol adducts. These 
highly selective reactions are the outcome of an effective kinetic resolution where the 
"fast" reaction is highly diastereoselective. In the following Sections, a more detailed 
discussion on this significant achievement is provided. 
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1.3. Stereoselectivity in the second aldol reaction: stereocontrol elements of the aldol 
reaction  
1.3.1. Relative topicity of the aldol coupling: aldol reaction of an achiral  
enolate with an achiral aldehyde 
   The stereocontrol element influencing the stereochemical outcome of the aldol 
reaction of achiral reactants is the relative topicity of the coupling, also referred to as 
simple diastereoselctivity. The relative configuration of the two newly formed stereogenic 
centres is designated syn or anti as illustrated in Scheme 4. The stereochemical outcome 
of the reaction depends on which of the two π-faces of the enolate reacts with which of 
the two π-faces of the aldehyde. In the transition state, the orientation of these faces 
dictates the relative and absolute configuration of the newly formed stereogenic centres. 
Applying the CIP rules,26 the two π-faces for each reactant can be designated as Re or Si 
face. There are four possible combinations of reacting faces leading to two possible 
diastereisomers (Scheme 4).27, 28 
Scheme 4. Four possible stereoisomers from the reaction of enolate 16 and aldehyde 17. 
MO
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Me OR2
H
+
SiSi
Re Re R1
Me
R2
16 17
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18 syn 19 anti
ent-18 syn ent-19 anti
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 The relative topicity of aldol reaction is often directly dependent on the E/Z 
geometry of the enolate. In general, Z-enolates give syn aldols and E-enolates give anti 
aldols. The Zimmerman-Traxler model29 can be used to explain the observed relative 
topicity of aldol coupling. In this model the transition state is a six membered ring which 
forms by coordination of the enolate metal with the aldehyde. In the case of enolate 16 
and aldehyde 17, this coordination leads to formation of four chair-like transition states 
with different orientations of the substituents. Repulsive interactions between substituents 
on the aldehyde and enolate raise the relative energy of the transition state, decreasing the 
probability of the corresponding adduct being formed. In the case of a Z-enolate, 
destabilizing 1,3 diaxial repulsion between the substituents occurs in the TS19 that leads 
to anti aldol adducts,  thus the formation of syn aldol adduct is favoured via TS18 
(Scheme 5). 30, 31 R1 and R2 are achiral, therefore the products 18 and ent-18 are equally 
favoured. 
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Scheme 5. Zimmerman-Traxler transition states of enolate (Z)-16. 
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  In the case of a E-enolate, the formation of anti aldol can be explained by 
formation of a more stable chair-like transition state (Scheme 6). In this case, 
destabilizing 1,3 diaxial repulsion between the substituents occurs in the TS20 that leads 
to the syn aldol adduct,  thus the formation of the anti aldol adduct is favoured via TS21 
(Scheme 6). R1 and R2 are achiral, therefore the products 18 and ent-18 are equally 
favoured. 
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Scheme 6. Zimmerman-Traxler transition states of enolate (E)-16. 
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 The above model provides a simple explanation for the observed relative topicity 
of boron mediated (i.e., M = B in 16) aldol coupling of cyclic ketone 8 with aldehyde 7a 
(Scheme 3). In some reactions, the Zimmerman-Traxler model fails to predict the 
observed relative topicity of the aldol reaction. For example the titanium "ate" mediated 
aldol coupling of ketone 8 with aldehyde 7a favoured syn relative topicity (Scheme 3).23 
The relative topicity of aldol coupling is dependent on the nature of the metal, the size of 
the substituents on the reactants and the reaction conditions.32 Due to the lower Lewis 
acidity and higher nucleophilicity of the titanium "ate" enolate, an open transition state 
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might be postulated to rationalize the observed syn selectivity for this enolate.33 
Regardless of the E/Z enolate geometry, the syn product would be favoured in this type of 
aldol reaction as the competing anti transition states TS24 and TS25 possess 
unfavourable gauche interactions between the Me and R2 groups (Scheme 7).32 
Scheme 7. E/Z enolate open transition states models for titanium "ate" aldol reaction. 
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1.3.2.   Diastereofacial selectivity of the enolate: aldol reaction of a chiral 
enolate with an achiral aldehyde               
 There are two stereocontrol elements affecting the diastereoselectivity of aldol 
reaction of chiral enolate with achiral aldehyde. The first one is the relative topicity of the 
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coupling which was discussed in Section 1.3.1 and the second one is the enolate 
diastereofacial selectivity. In the aldol reaction of racemic chiral enolate 26 and aldehyde 
17 (Scheme 8), eight possible adducts can form. Considering the favoured product(s), 
diastereofacial selectivity of the enolate can be indentified from the absolute 
configuration of C2 of the favoured product. Usually, this reaction will not afford these 
diastereomeric products in equal amounts and some of the possible products might not 
form due to the high energy of their corresponding transition states relative to the other 
product’s transition states. 
Scheme 8. Aldol reaction of chiral racemic enolate 26 and aldehyde 17. 
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     In boron mediated aldol reaction of racemic chiral enolate (±)-8aa (R = MOM) 
with propanal, the Si face of the enolate 8aa is favoured (Scheme 9). Adduct (±)-32 was 
obtained in 79% yield from a 9:1 mixture of product diastereomers.34 The diastereofacial 
selectivity of the enolate 8aa can be designated from the absolute configuration of C3.  In 
this reaction, addition occurs from the stereoelectronically preferred and sterically more 
accessible side opposite the large substituent at C3 in half-chair 33. Thus, the 
diastereofacial selectivity of the enolate 8aa is 3,5-trans. 
Scheme 9. Aldol reaction of chiral racemic enolate of 8aa (R = MOM) with propanal 31. 
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1.3.3. Diastereofacial selectivity of the aldehyde: aldol reaction of an achiral 
enolate with a chiral aldehyde                  
       The stereochemical outcome of the aldol reaction of achiral enolate with chiral 
aldehyde can be predicted considering the two stereocontrol elements governing the 
stereoselectivity of this reaction (Scheme 10). One stereocontrol element is the relative 
topicity of the aldol coupling which can be identified by C2,3 syn/anti relative 
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configuration. Factors that affect the relative topicity of aldol coupling were previously 
discussed (Section 1.3.1). The second stereocontrol element is the diastereofacial 
selectivity of the aldehyde determined by C3,4 syn/anti relative configuration. There are 
eight possible products that can be formed in the aldol reaction of a racemic chiral 
aldehyde 34 with an achiral enolate 35. In a kinetically controlled reaction, the ratio of the 
diastereomers produced in this reaction reflects the relative stability of their transition 
states (Scheme 10). In the absence of any external chiral influences, such as a chiral 
catalyst, the diastereomeric products will be racemic.  
Scheme 10. The aldol reaction of chiral aldehyde 34 with enolate 35. 
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 The π-facial selective addition of nucleophiles to carbonyl compounds has been 
extensively investigated. Two modes of carbonyl activation of an aldehyde bearing a 
stereogenic centre at the α-position by a Lewis acid can be considered: "chelated" and 
"open-chain" (Felkin) transition states (Scheme 11). To anticipate which modes of 
activation are involved in a Lewis acid-substrate reaction, a number of factors should be 
considered, including the nature of the coordinating Lewis acid ( e.g. TiCl4  vs BF3.OEt2 )  
and the nature of the oxygen protecting group ( e.g. Bn vs t-BuMe2Si), and the reaction 
solvent ( e.g. THF vs CH2Cl2). The stereochemical outcome in each type of activation can 
be predicted by two different models: the Cram-chelate model and the Felkin-Anh 
model.35 
   In 1952, Cram and Abd-Elhafez demonstrated a model which predicts the 
stereochemical outcome of the nucleophilic addition on a chiral aldehyde with a bidentate 
Lewis acid.  Metal ion chelation to the carbonyl and β-oxygen substituents forms a six-
membered ring transition state 42 which has differentiated diastereofaces (Scheme 11). 
The nucleophile preferentially attacks the less hindered side of the transition state 42 
which affords the anti-Felkin product with 1,2-anti hydroxy-methyl relationship in the 
adduct 44 (Scheme 11). 36, 37 
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Scheme 11. Cram-chelate model and Felkin-Anh model. 
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Felkin38 and Anh39 proposed a model based on torsional strain 41 (Scheme 11) 
which proposes that attack of the nucleophile is anti to the largest substituent at an angle 
of 109˚ (Burgi-Dunitz trajectory)40 from the least hindered face of aldehyde carbonyl. The 
stereochemical outcome of the reaction based on this model is the Felkin product 43 with 
1,2-syn hydroxy-methyl relationship (Scheme 11). 
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    To illustrate how analysis of operational stereocontrol elements can relate to the 
stereochemical outcome of a reaction, consider the reaction of  aldehyde (R)-46 with 
enolate (Z)-45 which gives aldol adducts 47 and 48 in a 6:1 ratio (Scheme 12).30 Aldol 
reaction of Li-enolate (Z)-45 are known to give syn relative topicity as predicted by the 
Zimmerman-Traxler model. Addition to the aldehyde (R)-46 should preferentially occur 
from the Re face as predicted by the Felkin-Anh model. Therefore, addition of enolate 
(Z)-45 to the Felkin-Anh preferred Re face of the aldehyde (R)-46 via a closed 
Zimmerman-Traxler transition state model affords 47 as the major product of this 
reaction. Product 48 is obtained from the Zimmerman-Traxler transition state model (syn 
relative topicity) and arises from anti-Felkin addition. In this case, syn relative topicity is 
a stronger stereocontrol element than Felkin diastereoface selectivity of the aldehyde (R)-
46, as both product 47 and 48 form with syn relative topicity. 
Scheme 12. Analysis of stereocontrol elements in the aldol reaction of (R)-46 with (Z)-45. 
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Reaction of enolate of 6 with the racemic chiral aldehyde 7a via TS49 would 
preferentially give 1',6"-syn selectivity (Scheme 13).20 Depending on the enolate mediator 
1',3-syn or 1',3-anti can be obtained via TS49a or TS49b. Although TS49 has an 
unfavorable interaction between the carbonyl and cis β-oxygen of the ketal group, all 
other possible conformations with staggered relationships between the forming bond and 
the α-substituents have additional unfavorable steric or dipole interactions.20 
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Scheme 13. Aldol reaction of achiral enolate of 6 with racemic chiral aldehyde (±)-7a. 
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1.4.  Stereoselectivity in the aldol reaction with kinetic resolution 
1.4.1. Double stereodifferentiation and mutual kinetic enantioselection in the 
aldol  reaction: aldol reaction of a chiral enolate with a chiral aldehyde 
Diastereoselectivity of aldol reaction of a chiral racemic enolate with a chiral 
racemic aldehyde adds the elements of MKE and DS. To illustrate the distereoselectivity 
of such an aldol reaction, consider the aldol reaction of racemic chiral aldehyde (±)-7a 
and racemic chiral enolate of (±)-8 (Schemes 14 and 15). In the aldol reaction of two 
racemic reactants, there are four possible parallel reactions occurring simultaneously. 
Reaction of each enantiomer of enolate of 8 with racemic aldehyde (±)-7a can give up to 
eight adducts: four each from like and unlike combination of reacting enantiomers. 
Seebach and Prelog41 proposed the terms like and unlike to differentiate the possible 
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reactions of chiral reactants. Like (the same configuration) and unlike (the opposite 
configuration) are defined with respect to the configuration of C3 of 8 and C6 of 7a.25 
Four adducts (50a-d) from the like reaction of enolate of (3S)-8 with (S)-7a (Scheme 14) 
are the enantiomers of the four adducts (ent-50a-d) from the enantiotopos like reaction of 
(3R)-8 with (R)-7a (Scheme 15). The enantiotopos reactions have a non-superimposable 
mirror image relationship.19 
Scheme 14. Aldol reaction of enolate of (3S)-8 with racemic aldehyde (±)-7a. 
S
OOO
6
(S)-7a S S S
O HO
S S S
O HO
S S S
O HO
S S S
O HO
OO OO OOOO
OO OOOO OO
S
OOO
6
S
O O
S
OM
3
(S)
(R)-7a
enolate of
   (3S)-8
S S S
O HO
S S S
O HO
S S S
O HO
S S S
O HO
OOOOOO OO
OOOO OO OO
50a 50b
50c 50d
50e 50f
50g 50h
like
unlike
(S) (S)
(R)
(R) (R)(S)
(S)
(S)
(S)
(S) (S) (S)
(S)
(S)(S) (R)
kSS
kSR
OR
OR OR
OROR
OR OR
OROR
 
 
Similarly, the four adducts from the unlike reaction of enolate of (3R)-8 with (R)-
7a are the enantiomers of the four adducts from the enantiotopos unlike reaction of 
enolate of (3S)-8 with (S)-7a. Due to the symmetry relationship, the like reaction of 
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enolate of (3S)-8 with (S)-7a and the like reaction of enolate of (3R)-8 with (R)-7a have 
identical rate constants (kSS = kRR) and diastereoselectivities. Similarly, the unlike 
reactions have identical rate constants (kSR = kRS) and diastereoselectivities.  
Scheme 15. Aldol reaction of enolate of (3R)-8 with racemic aldehyde (±)-7a. 
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Since there is no symmetry relationship between like and unlike reactions, these 
reactions are expected to have different rate constants and diastereoselectivities (kRR ≠ kRS, 
kSS ≠ kSR) (Schemes 14 and 15).  
  The difference between individual diastereoselectivities of the like and unlike 
reactions is referred to as double stereodifferentiation, DS.42 For each reaction in Schemes 
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14 and 15, the diastereoselectivity can be expressed by the ratio of the major product to 
the other products formed: 
DS : dr of the like reaction compared to dr of the unlike reaction 
or 
major product : others from the like reaction 
compared to  
major product : others from the unlike reaction 
 
The kinetic preference for reaction of an unlike or like combination of 
enantiomers of racemic reactants is referred to as mutual kinetic enantioselection, MKE. 
If one of the reactants is enantiopure, this kinetic preference is referred to as kinetic 
resolution, KR.  The adducts from an aldol reaction with KR will be enantiopure (or 
meso). When the aldol reaction of two racemic chiral reactants proceeds with significant 
mutual kinetic enantioselection (MKE) remarkably high diastereoselectivity can result. 
As a consequence of this phenomena, one of the eight possible racemic aldol adducts can 
form with high selectivity. Similar high diastereoselectivity is obtained in the aldol 
reaction which proceeds with kinetic resolution (KR).43 
One method for determining the MKE is by measuring the ratio of diastereomeric 
products from the like and unlike reaction which is equal to the ratio of the rate constants 
according to Horeau’s rule (Figure 3).44 This ratio is independent from the initial amount 
of racemic reactants and the degree of conversion. Similarly, in the reaction of an 
enantiopure species with a racemic reactant, the ratio of the rate constants can be 
determined by the ratio of diastereomeric products from the like and unlike reaction. 
However, in this case the ratios are only equal at low conversion or if racemic reactant is 
in large excess as the individual amount of each enantiomer must remain effectively 
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constant, otherwise the kinetic of the reaction is more complex in this case. In KR, the 
selectivity factor (s) is expressed by the ratio of kRS / kRR. 
RACEMIC 
        +
RACEMIC kSR = kRS
kSS = kRR
=
sum of the like products
sum of the unlike products=
MKE
  ENANTIOPURE
               +
EXCESS RACEMIC kSR
kSS
=
sum of the like products
sum of the unlike products=
KR
 
Figure 3.  Measurement of MKE and KR based on product distribution. 
As noted, diastereoselectivities of the like and unlike reactions are different. The 
reaction (like or unlike) that achieves higher diastereoselectivity is called the ‘matched’ 
reaction, whereas the reaction with lower or diminished diastereoselectivity is referred to 
as the ‘mismatched’ reaction. This terminology is used to explain the interaction involved 
in the aldol reaction of two chiral reactants considering their individual diastereofacial 
selectivity. 
Both mutual kinetic enantioselection (MKE) and kinetic resolution (KR)  are the 
consequence of significant differences between rate constants for the like and unlike 
reactions.23 The faster reaction is the combination of ‘matched’ pair of enantiomers, 
whereas the slower reaction is the combination of the ‘mismatched’ pair of enantiomers.   
1.4.2. Multiplicativity rule in the aldol reaction 
The diastereoselectivity for aldol coupling of chiral reactants can be 
qualitiatively predicted by application of the multiplicativity rule.  Masamune et al. 
rationalized the outcome of the reaction of chiral aldehyde (S)-53 with racemic enolate 
(±)-52 by applying the multiplicativity rule (Scheme 16).42 The aldol reaction of 
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enantiopure (S)-52 with an achiral aldehyde such as benzaldehyde 51 gives products 55 
and 56 in a ratio of 3.5:1. This ratio represents the diastereofacial selectivity of the enolate 
52. The absolute configuration of C2 indicates that the diastereofacial selectivity of the 
reacting enolate (S)-52 favours the reaction of the Re face. Similarly, the diastereofacial 
selectivity of aldehyde (S)-53 is identified by its aldol reaction with achiral enolate 54.  
This reaction affords products 57 and 58 in a ratio of 2.7: 1. In this case, the relative 
configuration of C3 and C4 results from the diastereofacial selectivity of the reacting 
aldehyde (S)-53 (Scheme 16). The absolute configuration of C3 in major products from 
the two reactions shows that (S)-53 and (S)-52 are a ‘matched’ pair. As expected, the 
reaction of this pair leads to the diastereoselectivity enhancement (59 and 60 in a ratio of 
8:1) as a result of favourable interaction between reacting faces of the two reactants 
(Scheme 16).  
In contrast, the diastereofacial selectivities of (S)-53 and (R)-52 counteract each 
other, thereby producing a low diastereomeric ratio (61 and 62 in a ratio of 1:1.5) 
(Scheme 16). Masamune hypothesized that the degree of asymmetric induction can be 
approximately calculated as E
 
x
 
A in the case of a ‘matched’ pair and E ÷ A in the case of 
a ‘mismatched’ pair where E and A are the diastereofacial selectivity of the two reaction 
components.  
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Scheme 16. Multiplicativity rule in aldol reaction of (S)-53 with racemic (±)-52. 
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Due to the complexity of the reaction, the multiplicativity of the diastereofacial 
selectivities is valid only under ideal conditions. In reality, all secondary effects on the 
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selectivity of the reaction are ignored. As a consequence of secondary effects number 
obtained does not necessarily give number observed (e.g. 9.5 versus 8 in Scheme 16). 
Furthermore, multiplicativity rule does not predict the facial selectivity value as a fixed 
number, the value varies depending on the achiral model substrate.42 
As Ward pointed out,19,23  the diastereoselectivity of the aldol reaction of enolate 
of 8 and aldehyde 7a, can be predicted and rationalized by extending the multiplicativity 
rule to incorporate relative topicity as the third stereocontrol element (Scheme 17). In that 
approach, the stereoselectivity of aldol coupling of chiral reactants is factorized into three 
stereocontrol elements: the diastereofacial selectivity for the ketone enolate (E; cis or 
trans with respect to the substituent at C3 of 8); the diastereofacial selectivity for the 
aldehyde (A; Felkin or nonFelkin with respect to the stereocenter at C6 of 7a) and the 
relative topicity of the aldol coupling (R; anti or syn with respect to the newly formed 
stereocenters in the products). 
According to the multiplicativity rule, the relative facilities for formation of each 
adduct can be predicted with respect to the biases of the individual stereocontrol elements 
in the reaction. Upon inspection of an adduct’s structure, the relative facility for its 
formation is predicted by the product of those stereocontrol elements that have been 
satisfied. The diastereoselectivity of the reaction can be predicted and rationalized 
according to the ratio of major adduct to the other adducts. 
  Each reaction in Scheme 17 can form up to eight possible adducts. The relative 
facility for each of the eight possible adducts from the boron mediated aldol reaction of 
(±)-8 (R = MOM) with the aldehyde (±)-7a (Scheme 17) can be predicted, provided the 
three stereocontrol elements are biased as: E (trans selective), R (anti selective) and A 
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(Felkin selective), the relative facility of the aldol adduct 11a is E·R·A, for adduct 11b is 
E·A and so on. The same concept can be applied to predict the relative facility for each of 
the eight possible adducts from the titanium "ate" mediated aldol reaction of (±)-8 (R = 
MOM) with the aldehyde (±)-7a (Scheme 17).  
Scheme 17. Three stereocontrol elements in the reaction of enolate of 8 with aldehyde 7a. 
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In this case three stereocontrol element are biased as follow:  E (trans selective), 
R (syn selective) and A (Felkin selective), thus the relative facility of the aldol adduct 11b 
is E·R·A, for adduct 11a is E·A and so on. 
As Masamune suggested,42 a simpler model reaction can be performed to 
estimate the individual diastereofacial selectivity of the reacting components. For 
example the reaction of the lithium enolate of 8 with benzaldehyde can be done to 
identify the ratio of 3,5-cis versus 3,5-trans adduct. From this result an estimation of the 
diastereofacial selectivity (E) of the enolate 8 may be obtained.19  
Diastereoselectivity of the ‘matched’ reaction (like reaction in boron mediated 
aldol reaction of (±)-8 with (±)-7a) and ‘mismatched’ reaction (unlike in boron mediated 
aldol reaction of (±)-8 with (±)-7a) can be predicted as the following equations (Scheme 
17): 
Predicted ‘matched’ reaction dr =  
major product from the like reaction/other products from the like reaction =  
(E·R·A) / (E + R + A). 
*** 
Predicted ‘mismatched’ reaction dr =  
major product from the unlike reaction /other products from the unlike reaction  =  
(R·A) / (E·A + E·R + 1). 
(assumption R, A > E) 
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   According to the multiplicativity rule, the diastereoselectivity of the aldol 
reaction of chiral reactants can be predicted and rationalized, provided the biases of 
stereocontrol elements are known.  
According to the concept outlined in Figure 3, MKE can be predicted by the ratio 
of kfast / kslow. The MKE of the boron mediated aldol reaction in Scheme 17 can be 
calculated as follows: 
Predicted relative facility of the ‘matched’ vs ‘mismatched’ reaction : 
MKE= kfast / kslow = (E·R·A + E + R + A) / (R·A + E·A + E·R + 1).  
In natural products total synthesis, the double stereodifferentiation in the aldol 
reaction can be advantageously employed to achieve high stereoselectivity provided the 
desired adduct is formed from a ‘matched’ reaction. However, when the desired isomer is 
not the product of a ‘matched’ reaction, the approach to the natural product must be 
redesigned. For example, Evan’s synthesis of 6-deoxyerythronolide B 63,45 initially 
incorporated the boron promoted aldol coupling of 67 and 68 which was expected to give 
the desired syn relationship between methyl groups at C6 and C8 in intermediate 65 
(Scheme 18).  
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Scheme 18. Evans retrosynthesis of 6-deoxyerythronolide B 63. 
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However, when the boron  mediated aldol reaction of 67 and 68 was attempted, 
the undesired aldol adduct 71 was formed through double stereodifferention (Scheme 19). 
The undesired  intermediate 71 with anti relationship between methyl groups at C6 and 
C8 was formed in 80% isolated yield as a single isomer from the ‘matched’ reaction of 67 
and 68.  
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Scheme 19. Aldol reaction of 67 and 68. 
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Therefore approach ‘a’ in the preparation of precursor 64 (Scheme 18) was 
abandoned. The retrosynthetic plan was redesigned and approach ‘b’ was pursued. In this 
approach, the intermediate 66 as single isomer was obtained from the ‘matched’ 
Mukaiyama aldol reaction of TMS enolate 70 and aldehyde 69 in 83% yield (Scheme 20).  
Scheme 20. Aldol reaction of 69 with 70.  
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1.4.3. Rational design of aldol reactions with kinetic resolution 
One of the most highly desired goals in modern synthetic organic chemistry is 
the ability to perform a chemical transformation in a way to obtain only one diastereomer 
or enantiomer as favoured product. There are a couple of advantages in development of 
stereoselective synthetic methods. First, the difficult process of isomeric separation is 
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eliminated. Second, the valuable starting material is not transformed into undesirable 
stereoisomers. Furthermore, by controlling the stereochemical outcome in a chemical 
transformation, any stereoisomeric analogue of a biologically active compound can be 
accessed.46 Thus, it is quite advantageous to be able to control the stereochemical 
outcome of the aldol coupling as one of the most important C-C bond formation strategies 
in asymmetric synthesis. Regarding this fact, the ability to design aldol reactions 
proceeding with KR can be useful in the asymmetric syntheses of stereochemically 
complex targets.  
   As discussed in Section 1.4.2, the stereoselectivity of aldol reaction of chiral 
reactants is factorized into three stereocontrol elements: diastereofacial selectivity for the 
ketone enolate (E), the diastereofacial selectivity for the aldehyde (A) and the relative 
topicity of the aldol coupling (R). According to the multiplicativity rule, the 
diastereoselectivity of the aldol reaction is qualitatively predicted and rationalized from 
the relative facilities of the aldol adducts forming in the reaction.19, 23 In a double 
stereodifferentiating aldol reaction proceeding with KR or MKE, the selectivity of the 
reaction (s = kfast / kslow) can be calculated quantitatively by assigning hypothetical values 
to the stereocontrol elements as follows (Table 1): 
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Table 1. Hypothetical values for selectivity of aldol reaction with MKE or KR.23 
Entry E R A s 
1 100 1 100 1 
2 100 3 100 2.8 
3 100 10 100 8.4 
4 10 10 10 3.4 
5 30 30 30 10 
  s = kfast / kslow = (E·R·A + E + R + A) / (R·A + E·A + E·R + 1) 
 
    This analysis demonstrates that the KR selectivity is limited by the least 
selective of the three stereocontrol elements (entries 1-3). Synthetically useful selectivity 
(s > 10) is obtained when each of these elements is highly biased (entry 5).23  
In order to design an aldol reaction with KR, a large body of previous research 
needs to be considered which indicates that all the three stereocontrol elements in the 
aldol reaction of chiral reactants can be modulated rationally by the choice of protective 
groups, enolate type and ligands and additives in order to obtain the desired selectivity.47 
Applying this approach, the Ward group designed new aldol reactions proceeding with 
KR with remarkably high stereoselectivity through screening various diastereomers of 
ketone enolate 8, different protecting groups on the enolate 8 and different enolate 
mediators.23,25   
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Scheme 21. Boron mediated aldol reactions of 8 with aldehyde 7a proceeding with KR. 
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Table 2. KR results for boron mediated aldol reactions. 
 
 
 
 
 
 
ketone KR yield% 
(-)-8as 15:1 80% 
(-)-8ss 9:1 77% 
(+)-8sa 14:1 80% 
(+)-8aa 14:1 74% 
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The best results of this extensive study are summarized in Scheme 21 and 22. 
Each of the diastereomers of 8 (racemic or enantiopure) reacts with the racemic aldehyde 
(±)-7a under optimized conditions (Scheme 21 and 22). Two adducts form from each 
reaction. The boron mediated reaction of each diastereomer of (±)-8 with aldehyde (±)-7a 
gave two adducts in favour of like adduct (Scheme 21). The Titanium "ate" mediated 
reaction of each diastereomer of (±)-8 with aldehyde (±)-7a gave two adducts in favour of 
unlike adduct (Scheme 22). 
Unlike and like reactions occurred with similar facility and both reactions 
proceeded with the same diastereofacial selectivity of the aldehyde (Felkin: 1", 6"-syn) 
and the same diastereofacial selectivity of the enolate (3,5-trans). The boron and titanium 
"ate" mediated aldol reactions differed in the aldol relative topicity; 5, 1"-anti in the boron 
mediated reaction versus 5, 1"-syn in the titanium "ate" mediated reaction.  
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Scheme 22. Titanium "ate" mediated aldol reactions of 8 with aldehyde 7a proceeding 
with KR. 
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Table 3. KR results for titanium "ate" mediated aldol reactions. 
 
 
 
 
ketone  KR yield% 
(-)-8as 1:8 66% 
(-)-8ss 1:9 67% 
(-)-8sa     1:>20 81% 
(-)-8aa   1:16 72% 
36 
  
Together with the high diastereofacial selectivity of the aldehyde 7a and enolate 
8, the use of enolate mediators, LDA / Ti(OiPr)4 or (C6H11)2BCl / Et3N which strongly 
favoured syn or anti relative topicity, resulted in strongly biased stereocontrol elements. 
Thus, this design paradigm efficiently leads to the aldol reactions with remarkable 
selectivity through KR (and MKE).23, 25 These highly enantioselective aldol reactions with 
KR were employed in the total synthesis of polypropionate natural products such as 
membrenone B,19 siphonarin B,17 baconipyrone A and C,17 and ent-caloundrin B48 by the 
Ward group. In this research, the scope and limitations of this design were explored and 
the obtained results are discussed in the following chapter.  
 
 
 
 
 
 
 
 
 
 
 
 
37 
  
2. RESULTS AND DISCUSSION 
 
2.1.  Research objectives 
Given the remarkable results discussed in Section 1.4.3, the goal of this research 
was to explore the scope and limitations of the design paradigm for aldol reactions with 
KR. Thus various α-substituted racemic aldehydes with an ethylene ketal, dithiolane, or 
dithiane group at the β position were reacted with boron and titanium "ate" enolates of 8 
under the previously optimized conditions. Those conditions resulted from extensive 
studies on the reaction of aldehyde 7a with various enolates of 8 (Schemes 21 and 22). 
Each of the aldehydes 7b-h had one or two structural feature(s) different from aldehyde 
7a (Scheme 23). 
As explained in the introduction, aldehyde 7a is known to react with high Felkin 
diastereoface selectivity. The influence of a heteroatom substituent at the aldehyde β-
position on diastereoface selectivity was investigated and both chelation control and 
'open' transition state models have been proposed to explain the observed stereoselectivity 
for additions of nucleophiles (Section 1.3.3).  In addition, it has been reported recently 
that aldehydes bearing a β-dithiolane groups also have high Felkin diastereofacial 
selectivity (A).49 According to the multiplicativity rule, if the three stereocontrol elements 
governing the stereoselectivity of the aldol reaction are highly biased, these reactions 
should proceed with KR. Previous work has shown that enolates of 8ss have high 
diastereoface selectivity resulting in aldol adducts with 3,5-trans relative configuration. 
Similarly, boron and titanium "ate" enolates of 8ss were highly selective giving aldol 
adducts with 5,1"-anti and 5,1"-syn relative configuration, respectively. Thus, to explore 
38 
  
the scope and limitations of this approach, the stereoselectivities of aldol reactions of 
aldehydes (±)-7b-h with ketones (±)-8ss (R = MOM or Et3Si) via the boron and titanium 
"ate" enolates were investigated (Scheme 23). 
Scheme 23. Research objectives. 
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Initially this investigation was performed using racemic reactants. The advantage 
of using racemic reactants is that both the diastereoselectivities of the individual like and 
unlike reactions and the MKE can be obtained from the analysis of the product 
distribution of a single reaction; the disadvantage is that the increased number of possible 
products complicates the analysis. Furthermore, an assessment of the three stereochemical 
control elements is also obtained from the product distribution and can aid in 
understanding of the factors governing the diastereoselectivity of the reaction. Based on 
the precedent established by the previous results23, 25 the expectation was that these 
reactions would show high levels of MKE under optimized conditions. The MKE was 
measured for each reaction by determining the ratio of products from the like and unlike 
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reactions. According to Horeau’s rule44 the MKE is equal to the ratio of rate constants for 
the like and unlike reactions and the selectivity constant (s) in the related kinetic 
resolution where one reactant is enantiopure and the other one is racemic. To demonstrate 
that conjecture the boron and titanium "ate" mediated aldol reactions of enantiopure 8ss 
(R = MOM) with aldehyde (±)-7f were shown to proceed with KR under condition where 
high MKE was observed using (±)-8ss (R = MOM).  
The following questions were addressed in this research:  
1. Is it possible to extend the highly selective aldol reactions of 8ss with aldehyde 7a to 
aldehydes 7b-h based on their expected high Felkin diastereoface selectivity? 
2. How does the nature of the structural differences between aldehydes 7a and 7b-h affect 
the stereoselectivity of their aldol reactions?  
2.2.  Synthesis of starting materials  
To pursue the objectives of this research, it was first necessary to synthesize the 
starting materials. Using procedures established in the Ward group, racemic and 
enantiopure ketone 8ss (R = MOM or Et3Si) were synthesized.23, 25 Racemic ketone 8ss 
(R = H) was prepared by TiCl4 mediated aldol reaction of silyl enol ether 15 with 
aldehyde 7a (Scheme 24).20 Enantiopure ketone 8ss was obtained from (S)-14 catalyzed 
aldol reaction of ketone 6 with aldehyde 7a followed by isomerization of (+)-8as (R = H) 
to obtain (-)-8ss (R = H) (> 98% ee) in 60 % yield over two steps (Scheme 25).22  
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Scheme 24. Synthesis of racemic ketone 8ss (R = MOM or Et3Si). 
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The MOM protection of racemic and enantiopure 8ss (R = H) were done 
according to the newly developed procedure in the Ward group. This method includes 
addition of MBDA (4,4'-Methylenebis(N,N-dimethylaniline)) and MOMCl to the ketone 
8ss (R = H) at room temperature (Schemes 24 and 25).  
 
 
 
 
 
41 
  
Scheme 25. Synthesis of enantiopure ketone 8ss (R = MOM or Et3Si). 
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Aldehyde 7a was prepared using the known route starting from commercially 
available diester 74.7 Aldehydes 7a and 7b were obtained from the common intermediate 
75 by protection with the desired ketal group following by LAH reduction of the resulting 
esters 76 and 77 and IBX oxidation of the corresponding alcohols 78 and 79 (Scheme 26).  
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Scheme 26. Preparation of aldehydes 7a and 7b. 
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Compound 81, obtained from Claisen condensation of 80,17was a common 
intermediate for syntheses of aldehydes 7c,50 7d17 and 7e. Protection of 81 with desired 
ketal protecting group, followed by LAH reduction of the resulting esters 82, 83, and 84 
and IBX oxidation of the corresponding alcohols 85, 86, and 87 gave aldehydes 7c, 7d, 
and 7e, respectively (Scheme 27). 
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Scheme 27. Preparation of aldehydes 7c, 7d and 7e. 
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Aldehydes 7f and 7g were obtained by protection of commercially available 88 
with desired ketal protecting group, followed by LAH reduction of the resulting esters 89 
and 90 and IBX oxidation of the corresponding alcohols 91 and 92 (Scheme 28). 
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Scheme 28. Preparation of aldehydes 7f and 7g. 
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Aldehyde 7h was prepared in two steps by dithiolane protection of butanal 93 
followed by Vilsmeier reaction of the resulting 94 according to the known procedure 
(Scheme 29).51 
Scheme 29. Preparation of aldehyde 7h. 
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2.3. The diastereoselectivity of the aldol reaction of 8ss with aldehydes 7a-h 
2.3.1. Anti-selective relative topicity with boron enolates 
The boron mediated aldol reaction of (±)-8ss (R = MOM, Et3Si or Ac) with the 
aldehyde (±)-7a occurs with high mutual kinetic enantioselection (MKE) in favour of the 
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like reaction.23 The like adduct 72a (Figure 4) was isolated from the reaction of MOM 
protected derivative in excellent yield (86 %) and high diastereoselectivity (like: unlike in 
a ratio of 15:1) (Scheme 30). Aldol reactions of cyclic ketones such as 8ss via their boron 
enolates are known to proceed with high anti relative topicity (R).23,25 The boron enolate 
of 8ss is highly 3,5-trans selective (E) and the aldehyde 7a reacts with high Felkin 
diastereofacial selectivity (A). Thus, the three stereocontrol elements governing the 
diastereoselectivity of this reaction are highly biased leading to high MKE. The aldehydes 
7b-g were expected to have high Felkin diastereofacial selectivity (A) 49 thus the boron 
mediated aldol reactions of (±)-8ss (R = MOM or Et3Si) with the aldehydes (±)-7b-g were 
expected to occur with high MKE in favour of the like reaction according to the design 
paradigm (Scheme 30).  
Scheme 30. Aldol reactions of (±)-7a-g with the boron enolates of (±)-8ss (R = MOM or 
Et3Si). 
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As expected, reactions of (±)-7b-g with the boron enolate of (±)-8ss (R = MOM or 
Et3Si) gave adducts (±)-72b-g respectively in excellent yields and with high 
diastereoselectivities. The yields of the reactions varied from 76 to 89% and the MKE’s 
for the reactions (ratio of like adduct (±)-72b-g and unlike adduct (±)-73b-g) varied from 
10:1 to >20:1. These reactions proceed with remarkably high MKE in favour of the like 
reaction under optimized condition.23 Unlike adducts (±)-73b-g were observed as the 
minor products from these reactions in most cases (Table 4 and Figure 4). The boron 
mediated aldol reactions are presumed to proceed via a "closed" transition state, thus the 
ratio of (±)-72b-g and (±)-73b-g adducts (like and unlike adducts) is dependent on the 
relative rate constants for reactions of the like combination of enantiomers of 7b-g and 
8ss via a chairlike transition state (anti relative topicity) to give (±)-72b-g versus 
reactions of the unlike combination of enantiomers via a twist boat-like transition  state 
(syn relative topicity) to give (±)-73b-g.23 
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Table 4. Reactions of aldehydes (±)-7a-g with boron enolates of (±)-8ss or (-)-8ss. 
entry ketone R aldehyde (equiv) 
aldol adductsa (ratio)b; 
conversionc (%) 
total isolated 
yield % 
1 (±)-8ss MOM 7a (2) 
(±)-72a : (±)-73a  
 (15:1);  92% 
----- 
2 (±)-8ss Et3Si 7a (2) 
(±)-72a : (±)-73a  
(25:1);  95% 
----- 
3 (±)-8ss MOM 7b (2) (±)-72b : (±)-73b (10:1); 91% 89 
4 (±)-8ss Et3Si 7b (2) (±)-72b : (±)-73b (11:1); 92% 77 
5 (±)-8ss MOM 7c (2) (±)-72c : (±)-71c (>20:1); 92% 89 
6 (±)-8ss Et3Si 7c (2) (±)-72c : (±)-73c (>20:1); 93% 76 
7 (±)-8ss MOM 7d (2) (±)-72d : (±)-73d (17:1); 88% 84 
8e (±)-8ss Et3Si 7d (2) (±)-72d : (±)-73d (>20:1); 89% 79 
9 (±)-8ss MOM 7e (2) (±)-72e: (±)-73e (>20:1); 96% 89 
10 (±)-8ss Et3Si 7e (2) --------- ------- 
11 (±)-8ss MOM 7f (2) (±)-72f : (±)-73f (>20:1); 90% 66 
12 (±)-8ss Et3Si 7f (2) (±)-72f : (±)-73f (>20:1); 97% 75 
13 (±)-8ss MOM 7g (2) (±)-72g : (±)-73g (>20:1); 94% 78 
14 (±)-8ss Et3Si 7g (2) ------ ------- 
15 (-)-8ss MOM 7f (3) (+)-72f : (+)-73f (>20:1); 99% 81 
a)Refer to Figure 4 for 72a-g and 73a-g structures. b) Determined by 1H NMR of the crude reaction mixture. c) 
Estimated from the ratio of adducts and starting ketone present in the crude reaction mixture. d) 71c was assigned as 
sulfoxide formed during the work up.  e)  Reaction time, 16 h. 
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Figure 4. like and unlike adducts for aldehydes 7a-g. 
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Reaction of (±)-7b with the boron enolate of (±)-8ss (R = MOM) gave aldol 
adduct (±)-72b with excellent yield (80%) and high diastereoselectivity (Table 4 entry 3). 
This reaction can give up to eight diastereomers assuming there is no isomerization of 
starting ketone 6ss or aldol adducts during the reaction and workup. Considering the 
obtained results, this reaction occurred with high MKE in favour of the like reaction (like: 
unlike in a ratio of 10:1). Adduct (±)-73b was isolated as the minor product of this 
reaction. The MKE of this reaction was confirmed after assigning the relative 
configurations of the products (Section 2.4.1). Reaction of the Et3Si-protected derivative 
of (±)-8ss with (±)-7b gave similar diastereoselectivity ((±)-72b:(±)-73b, 11:1) (Table 4 
entry 4). However, the yield of this reaction was lower due to retro-aldol upon extending 
the reaction time after addition of aldehyde (±)-7b.   
Among the aldehydes 7b-g, reactions of 'acyclic' aldehydes 7c or 7f or 7g gave 
very high diastereoselectivities compared to cyclic aldehyde 7b (Table 4 entries 6 and 11-
13). The adducts from these reactions (±)-72c, (±)-72f and (±)-72g result from a like 
reaction of these aldehydes with 8ss and were the only products detected. 
In the reaction of aldehyde (±)-7d with the boron enolate of (±)-8ss (R = Et3Si), 
the major adduct (±)-72d was obtained in high yield 76% and with higher selectivity by 
extending the reaction time to 16 h (3 h, (±)-72d:(±)-73d = 11:1; 16 h, (±)-72d:(±)-73d = 
>20:1) (Table 4 entry 8). The adduct (±)-72f (R = Et3Si) (Figure 4) was obtained as single 
product from reaction of (±)-7f with (±)-8ss (R = Et3Si) (Table 4 entry 12). The yield of 
this reaction was diminished by retro-aldol upon extending the reaction time, whereas the 
yield of (±)-72f (R = MOM) was not affected by extending the reaction time.  
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Aldehyde 7g was prepared to investigate the influence of a β-dioxolane group 
versus a β-dithiolane group (cf. 7f) on the aldol reaction diastereoselectivity (Scheme 31). 
Reactions of aldehyde (±)-7g with the boron enolate of (±)-8ss (R = MOM) gave results 
to the analogous to the analogous reactions with aldehyde (±)-7f (Table 4 entries 11 and 
13). Boron mediated aldol reactions of 8ss (R = MOM) with the aldehydes 7f and 7g were 
highly diastereoselective affording like adducts (±)-72f and (±)-72g, respectively, as the 
only adducts detected.  
2.3.2. Syn-selective relative topicity with titanium "ate" enolates 
The titanium "ate" mediated aldol reaction of (±)-8ss (R = MOM) with the 
aldehyde (±)-7a proceeded with high MKE in favour of the unlike reaction. Similar 
reaction with (±)-8ss (R = Et3Si) showed low MKE.23 Under the optimized conditions this 
reaction strongly favours syn relative topicity. The optimized conditions for aldol reaction 
via titanium "ate" enolate involve addition of freshly prepared LDA (1.1 equiv) to the 
ketone (±)-8ss (R = MOM) at -78 ˚C followed by addition of Ti(OiPr)4 (2.2 equiv or 
more) at -78 ˚C, warming to -50 ˚C bath for 30 min (required for transmetalation), and 
addition of the aldehyde at -78 ˚C. The unlike adduct (±)-73a (Figure 4) was isolated from 
the reaction of the MOM protected 8ss derivative in excellent yield (79 %) and high 
diastereoselectivity ((±)-73a: (±)-72a in a ratio of 11:1) (Scheme 31).23  
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Scheme 31. Aldol reactions of (±)-7a-g with the titanium "ate" enolates of (±)-8ss (R = 
MOM or Et3Si). 
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The scope of the aldol reactions of (±)-8ss (R = MOM or Et3Si) via its titanium 
"ate" enolate was investigated by applying the optimized conditions to the reactions with 
the aldehydes (±)-7b-g (Scheme 31 and Table 5). The MKE for these reactions were 
determined after establishing the relative configurations of the adducts (Section 2.4.4). 
Reaction of (±)-7b with the titanium "ate" enolate of (±)-8ss (R = MOM) afforded 
bisaldol adduct (±)-73b (Figure 4) as the major product in 73 % yield (Table 5 entry 3). 
Under optimized conditions, the reaction proceeded with remarkable MKE in favour of 
unlike adduct (±)-73b ((±)-73b: (±)-72b in a ratio of 13:1). The MKE was improved using 
4.4 equivalent of Ti(OiPr)4 (cf. 2.2 equiv; (±)-73b:(±)-72b = 9:1). This result is consistent 
with the Thornton52 finding of improved selectivity of titanium "ate" mediated aldol 
reactions using an excess of Ti(OiPr)4.  
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Table 5. Reactions of (±)-7a-g with titanium "ate" enolates of (±)-8ss or (-)-8ss. 
entry ketone R aldehyde  
(equiv) 
aldol adductsa (ratio)b; 
conversionc (%) 
total isolated 
yield % 
1 (±)-8ss MOM           7a (2) (±)-72a : (±)-73a  
(1:10); 91% 
------ 
2 (±)-8ss Et3Si           7a (2) (±)-72a : (±)-73a  
(1:2); 88% 
------ 
  3d (±)-8ss MOM   7b (2)  (±)-72b : (±)-73b 
 (1:13); 96% 
79 
4 (±)-8ss Et3Si   7b (2) (±)-72b : (±)-73b  
(1:2); 89% 
66 
5 (±)-8ss MOM   7c (2) (±)-72c : (±)-73c  
(1:4); 90% 
88 
6 (±)-8ss Et3Si   7c (2) (±)-72c : (±)-73c  
(3:1); 98% 
84 
7 (±)-8ss MOM   7d (2) (±)-72d : (±)-73d  
(1:8); 94% 
77 
8 (±)-8ss Et3Si   7d (2) (±)-72d : (±)-73d 
(1.6:1); 73% 
53 
9 (±)-8ss MOM   7e (2) (±)-72e : (±)-73e  
(2:1); 94% 
82 
10 (±)-8ss Et3Si   7e (2) ------ ------- 
 11d (±)-8ss MOM   7f (2) (±)-72f : (±)-73f  
(1:6); 92% 
77 
12 (±)-8ss Et3Si   7f (2) (±)-72f : (±)-73f 
 (3:1); 87% 
75 
 13d (±)-8ss MOM   7g (2) (±)-72g : (±)-73g  
(1:3); 93% 
71 
14 (±)-8ss Et3Si   7g (2) ----- ----- 
  15d (-)-8ss MOM   7f (3) (+)-72f : (+)-73f  
(1:4); 88% 
77 
a) Refer to Figure 4 for 72a-g and 73a-g structures. b) Determined by 1H NMR of the crude reaction mixture. c) 
Estimated from the ratio of adducts and starting ketone present in the crude reaction mixture. d) 4.4 equiv of 
Ti(OiPr)4 was used. 
53 
  
 
Contrary to the reactions of aldehydes 7c-g, extending the reaction time up to 17 
hours after addition of aldehyde (±)-7b to the titanium "ate" enolate (±)-8ss (R = MOM) 
improved the selectivity of the reaction, however allowing more time for transmetalation 
(0.5-2 h) prior to the addition of (±)-7b had no effect on the ratio of the unlike:like 
adducts.  
Similar reaction with Et3Si derivative of 8ss had considerably lower MKE ((±)-
73b: (±)-72b in a ratio of 2:1) (Table 5 entry 4). Extending the reaction time did not affect 
the diastereoselectivity of this reaction. Similar selectivity was observed in the titanium 
"ate" mediated aldol reaction of aldehyde (±)-7b with (±)-8ss (R = Et3Si) ((±)-73b: (±)-
72b in a ratio of 2:1) (Table 5 entry 2).23  
The diastereoselectivity decreased markedly by changing from cyclic to acyclic 
aldehydes. There is significant difference between diastereoselectivities of reactions of 
(±)-8ss (R = MOM) with the cyclic aldehydes such as (±)-7a or (±)-7b and acyclic 
aldehydes (±)-7c-g (Table 5: entries 1 and 3 versus entries 5, 7, 9, 11 and 13). Among the 
acyclic aldehydes 7c-g, the MKE for the reaction varied from 8:1 to 1:2.  Unexpectedly, 
the reactions of acyclic aldehydes (±)-7c-d or (±)-7f with (±)-8ss (R = Et3Si) occurred 
with low to moderate MKE in favour of like reaction (Table 5: entries 6, 8 and 12). These 
results indicate that among acyclic aldehydes changing the protective group on the 
enolate (±)-8ss from MOM to Et3Si causes the reaction to proceed with very low MKE 
moderately favouring the like reaction with anti relative topicity. Similar selectivity was 
observed in the reaction of aldehyde (±)-7e with (±)-8ss (R = MOM) (Table 5 entry 9). 
Contrary to the observed results for the reaction with aldehyde 7b, the diastereoselectivity 
of this reaction was not improved by increasing the amount of Ti(OiPr)4 reagent used. 
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Extending the reaction time for reaction of aldehyde (±)-7d with (±)-8ss (R = 
MOM) did not improve the diastereoselectivity. Also, allowing more time for 
transmetalation (0.5-2 h) prior to the addition of aldehyde (±)-7d had no effect on the 
products ratio. Contrary to the report by Thornton52 and observed in the reaction of 
aldehyde (±)-7b, increasing the amount of Ti(OiPr)4 reagent (4.4 or 8.8 equiv) had no 
effect on the diastereoselectivity of titanium "ate" mediated reactions of aldehyde (±)-7d 
with (±)-8ss (R = MOM or Et3Si). Using excess TiCl(OiPr)3 reagent instead of Ti(OiPr)4 
reagent for preparation of the enolate did not improve the diastereoselectivity of this 
reaction. The TiCl(OiPr)3 used in this study  was prepared by two different methods; one 
method included the neat reaction of 3 mole Ti(OiPr)4 with 1 mole TiCl4 at 0 ˚C followed 
by distillation of the TiCl(OiPr)3; 53 the other procedure 54 involved in situ preparation of  
TiCl(OiPr)3 by addition of the same two reagents in the same ratio in DCM as a solvent at 
0 ˚C. TiCl(OiPr)3 prepared by both methods were used for the reaction of aldehyde (±)-7d 
with (±)-8ss (R = MOM) in separate experiments. None of these experiments led to an 
improvement of the diastereoselectivity of the reaction. 
In another attempt to improve the diastereoselectivity of the reaction of (±)-8ss 
(R = MOM) with aldehyde (±)-7d, Ti(OiPr)4 was added to the "amine free" Li-enolate of 
(±)-8ss (R = MOM) prior to the addition of aldehyde (±)-7d. Reaction of (±)-8ss (R = 
MOM) with LDA followed by addition of TMSCl gave the corresponding trimethylsilyl 
enol ether which was treated with t-BuLi to give the "amine free" Li-enolate of (±)-8ss (R 
= MOM).  Subsequent reaction with (±)-7d gave two bisaldol adducts (±)-73d and (±)-
72d with a ratio of 3:1 in favour of the unlike adduct (±)-73d. Thus replacing LDA 
enolate by "amine free" Li-enolate did not affect the diastereoselectivity of the reaction. 
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2.3.3. MKE and KR from the aldol reactions of (±)-8ss (R = MOM or Et3Si) 
with aldehyde (±)-7f and (±)-7h 
The aldehydes 7f and 7h were designed for application in a projected synthesis 
of (+)-membrenone A 98 (Scheme 32). The aldol adduct 96 with desired stereochemistry 
should be obtained from reaction of aldehyde (±)-7f with the titanium "ate" enolate of 
enantipure 95. Alternatively, reaction of aldehyde (±)-7h with the boron enolate of 
enantipure 95 should provide the synthetically analogous adduct 97 (Scheme 32). 
Desulphurization of 96 or 97 would give the same product. Unfortunately, the reactions of 
(±)-8ss (R = MOM or Et3Si) with (±)-7h via the boron enolate showed low MKE. 
To assess the possibility of achieving KR with aldehyde 7f, reactions with both 
boron and titanium "ate" enolates of (-)-8ss (R = MOM) were investigated.  
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Scheme 32. Synthetic plan for (+)-membrenone A 98. 
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Reactions of aldehyde (±)-7f with the boron enolates of (±)-8ss (R = MOM or 
Et3Si) were highly selective giving one adduct (±)-72f (R = MOM or Et3Si) (Table 4: 
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entries 11 and 12). Both reactions occurred with very high MKE (>20:1). As noted in 
Section 2.1, the MKE observed for reaction of racemic reactants should be equal to the 
selectivity constant (s) in the analogous KR where one reactant is enantiopure and the 
other is racemic.23 To validate this opportunity to achieve KR, the reaction of aldehyde 
(±)-7f with the boron enolate of highly enantioenriched (-)-8ss (R = MOM) was 
conducted under the reaction conditions used for the reaction of racemic reactants. As 
expected, enantiopure (+)-72f (from the like reaction) was obtained as the sole product in 
excellent yield 81% (Scheme 33) (Table 4 entry 15). 
Scheme 33. Reaction of (±)-7f with the boron enolate of (-)-8ss (R = MOM). 
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Reaction of aldehyde (±)-7f with the titanium "ate" enolate of (±)-8ss (R = 
MOM) gave two aldol adducts (±)-73f and (±)-72f with a ratio of 6:1 in favour of the 
unlike adduct (±)-73f (Table 5 entry 11). To achieve that selectivity required the use of 
4.4 equivalent of Ti(OiPr)4 (cf. 2.2 equiv; (±)-73f: (±)-72f, 4:1). The use of 8.8 equivalent 
of Ti(OiPr)4 did not improve the selectivity further. Reaction of aldehyde (±)-7f with the 
titanium "ate" enolate of highly enantioenriched (-)-8ss (R = MOM) under these 
conditions gave an inseparable 4:1 mixture of (+)-73f and (+)-72f, respectively (Scheme 
34).  
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Scheme 34. Reaction of (±)-7f with the titanium "ate" enolate of (-)-8ss (R = MOM). 
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2.3.4. Summary of results for boron and titanium "ate" mediated reactions 
(±)-8ss (R = MOM or Et3Si) with aldehydes (±)-7a-g 
Reactions of aldehydes (±)-7a-g with the boron enolates of (±)-8ss (R = MOM or 
Et3Si) were highly selective and proceeded with high MKE in favour of the like adducts 
72a-g (Scheme 35 and Table 4). The ratio of products is dependent on the relative rate 
constants for the like and the unlike reactions. The like reactions of aldehydes 7a-g with 
the boron enolate of 8ss proceed via chair-like transition state 99 affording products 72a-g 
with anti relative topicity (Scheme 36). The unlike reactions of aldehydes 7a-g with the 
boron enolate of 8ss presumably proceed via twist boat-like transition state 100 giving 
products 73a-g with syn relative topicity. 
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Scheme 35. Summary of boron and titanium "ate" mediated aldol reactions of (±)-8ss (R 
= MOM or Et3Si) with the aldehydes (±)-7a-g. 
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The chair-like transition state 99 is favoured over the twist boat-like transition 
state 100, thus like adduct is major product from the aldol reaction via boron enolate 
(Scheme 36). Under the optimized conditions for boron mediated aldol reaction, anti 
relative topicity is strongly favoured, thus all three stereocontrol elements of the reaction 
are strongly biased leading to high MKE. The selectivity of this reaction was independent 
of the structure of the aldehyde (acyclic or cylic) and nature of the β-protecting group on 
the aldehyde (dithiolane, dioxolane or dithiane). Also nature of the protecting group on 
the enolate 8ss (MOM or Et3Si) had little effect on the diastereoselectivity of this 
reaction. This is consistent with the finding that the β-protecting group has minimal effect 
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on the diastereoselectivity of aldol reactions of boron enolates of β-alkoxy  acyclic chiral 
ketones.23  
Scheme 36. Transition states for boron mediated reaction of 8ss with aldehydes 7a-g. 
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Reactions of aldehydes (±)-7a-g with the titanium "ate" enolate of (±)-8ss (R = 
MOM) gave moderate to good MKE (Scheme 35 and Table 5). Comparison of the results 
of boron and titanium "ate"  mediated aldol reactions (Tables 4 and 5) indicates that the 
boron mediated aldol reactions generally proceed with much higher MKE than titanium 
"ate" mediated aldol reactions in both MOM and Et3Si protected (±)-8ss.  
As Ward has pointed out,23 the structure and aggregation state of titanium "ate" 
enolates are uncertain and it is not clear whether the competing transition states for the 
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like and unlike reactions are the same type (e.g., "closed" chair versus twist-boat) or 
different types (e.g., "closed" versus "open"). Results of titanium "ate" mediated aldol 
reactions of cyclic or acyclic aldehydes with MOM protected 8ss show that presence of β-
dithiolane protecting group versus β-dioxolane protecting group on the aldehyde leads to 
higher selectivity (Table 5: entry 3 versus entry 1 and entry 7 versus entry 5). This can be 
presumably caused by coordination of titanium centre with the β-dithiolane protecting 
group as a result of the strong affinity of Ti(IV) for sulphur. Such an interaction would 
give octahedral geometry at titanium and facilitate aldol reaction via a transition state (cf. 
101) analogous to an  'open' transition state affording an unlike adduct (Scheme 37).  
The selectivity of the titanium "ate" mediated reaction of acyclic aldehydes (±)-
7c-d or (±)-7f with (±)-8ss drops significantly upon changing the protecting group of the 
enolates from MOM to Et3Si to the degree that in some cases like (anti) adduct is 
favoured over the unlike (syn) adduct (Table 5: entries 6, 8 and 12).  
A similar trend was observed in case of cyclic aldehydes (±)-7a and (±)-7b 
(Table 5: entries 2 and 4). The nature of MOM and Et3Si protecting group is different. As 
Ward pointed out,23 intramolecular coordination of Ti with O-MOM would give 
octahedral geometry of the titanium "ate" enolate and perhaps facilitate aldol reaction via 
an 'open' transition state 102 (Scheme 37). For the TES protected titanium "ate" enolate, 
the lower Lewis basicity of an O-TES versus O-MOM oxygen should diminish the 
tendency for intramolecular coordination with Ti(IV) thereby leaving an open site for 
coordination of the aldehyde carbonyl resulting in a 'closed' transition state 100.  The like 
adduct from the titanium "ate" enolate of Et3Si protected 8ss is presumably obtained via 
'closed' chair-like transition state 99. Whether the unlike reaction occurs via an 'open' 
transition state or 'closed' twist boat-like transition state 100 or combination of both 
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transition states, changing the protecting group on the enolate from MOM to Et3Si can 
affect the relative energies of the competing transition states and and facilitate formation 
of like adduct via a 'closed' chair like transition state 99 (Scheme 37). 
Scheme 37. Transition states for titanium "ate" mediated reaction of 8ss with aldehydes 
7a-g. 
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2.4.  Structure determination of aldol adducts 72 and 73  
2.4.1. Determination of the relative configurations of aldol adducts 72b and 
73b 
The adduct 72b was obtained as the major product from the boron mediated 
aldol reaction of 8ss (R = MOM) with the aldehyde 7b. The relative configuration of the 
adduct 72b was confirmed by reaction of this adduct with BF3·OEt3/(HSCH2)2 affording 
103 in 61% yield. The aldol adduct 72a with known relative configuration25 was obtained 
from boron mediated aldol reaction of 8ss (R = MOM) with the aldehyde 7a. Reaction of 
aldol adduct 72a with BF3.OEt3/(HSCH2)2 gave 103 (65% yield) establishing the relative 
configuration of 72b by correlation to 72a (Scheme 38). 
Scheme 38. Determination of the relative configuration of aldol adduct 72b (R = MOM). 
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Adduct 73b was obtained as the major product from titanium "ate" mediated 
aldol reaction of 8ss (R = MOM) with the aldehyde 7b. Reaction of 73b with 
BF3·OEt3/(HSCH2)2 gave 104 in 58% yield. Reaction of 73a (known relative 
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configuration) 25 with BF3·OEt3/(HSCH2)2 gave 104 in 68% yield establishing the relative 
configuration of 73b by correlation to 73a (Scheme 39).  
Scheme 39. Determination of the relative configuration of aldol adduct 73b (R = MOM). 
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Adduct 72b (R = Et3Si) was obtained as the major product from reaction of 
boron enolate of 8ss (R = Et3Si) with the aldehyde 7b. Removal of the silyl protecting 
group in 72b (R = Et3Si) by treatment with aqueous 30% HF solution gave 105 in 43% 
yield. Removal of the MOM ether in 72b (R = MOM) by treatment with TiCl4/PhSH gave 
105 in 26% yield.  
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Scheme 40. Determination of the relative configuration of aldol adduct 72b (R = TES). 
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Considering the relative configuration of 72b (R = MOM) previously established 
(Scheme 38), this result confirms the relative configuration of adduct 72b (R = Et3Si) 
(Scheme 40). 
2.4.2. Determination of the relative configurations of aldol adducts 72c and 
73c 
Adduct 72c was obtained as the major product from boron mediated aldol 
reaction of 8ss (R = MOM) with the aldehyde 7c. Desulphurization of 72c by treatment 
with Raney Ni gave 106 in 55 % yield. Raney Ni desulphurization of 72a (known relative 
configuration)25 also gave 106 thereby confirming the relative configuration of 72c by 
correlation to 72a (Scheme 41). 
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Scheme 41. Determination of the relative configuration of aldol adduct 72c. 
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Adduct 73c is the major product from titanium "ate" mediated aldol reaction of 
8ss (R = MOM) with the aldehyde 7c. Raney Ni desulphurization of 73c gave 107 in 42% 
yield. The same product was obtained by desulphurization of 73a with known relative 
configuration thereby confirming the relative configuration of 73c by correlation to 107 
(Scheme 42).  
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Scheme 42. Determination of the relative configuration of aldol adduct 73c. 
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2.4.3. Determination of the relative configurations of aldol adducts 72d and 
73d 
Adduct 72d was obtained as the major product from boron mediated aldol 
reaction of 8ss (R = MOM) with the aldehyde 7d. Reaction of 72d with 
BF3·OEt3/(HSCH2)2 gave 108 in 70% yield. The same product was obtained from reaction 
of 72b (of known relative configuration; Scheme 41) with BF3·OEt3/(HSCH2)2 in 55% 
yield thereby confirming the relative configuration of adduct 72d by correlation to 72b 
(Scheme 43).  
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Scheme 43. Determination of the relative configuration of aldol adduct 72d. 
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Adduct 73d was the major product from titanium "ate" mediated aldol reaction 
of 8ss (R = MOM) with the aldehyde 7d. Reaction of 73d with BF3·OEt3/(HSCH2)2 gave 
109 in 67% yield (Scheme 44).  
Scheme 44. Determination of the relative configuration of aldol adduct 73d. 
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The same product was obtained in 53% yield by treatment of 73b (of known 
relative configuration; Scheme 42) with BF3·OEt3/(HSCH2)2 thereby confirming the 
relative configuration of 73d by correlation to 73b (Scheme 44). 
2.4.4. Determination of the relative configurations of aldol adducts 72e and 
73e 
Adduct 72e was obtained as the major product from both the boron and titanium 
"ate" mediated aldol reactions of 8ss (R = MOM) with the aldehyde 7e. Both reactions 
also gave 73e as the minor product.  
Scheme 45. Determination of the relative configuration of aldol adduct 72e and 73e. 
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In order to assign the relative configuration of 72e, this adduct was 
desulphurized by treatment with Raney Ni to give 110 in 44% yield. The same product 
was obtained from desulphurization of 72b (Scheme 45). Because the relative 
configuration of 72b is known (Section 2.4.1), the relative configuration 72e is 
established by correlation to 72b. The relative configuration of 73e is tentatively assigned 
as shown in Scheme 45 in analogy with previous results.  
2.4.5. Determination of the relative configurations of aldol adducts 72f and 
73f 
Adduct 72f was obtained as the major product from boron mediated aldol 
reaction of 8ss (R = MOM) with the aldehyde 7e. In order to assign the relative 
configuration of 72f, enantiopure 114 was synthesized (Scheme 46). The enantiopure 
aldehyde (+)-112 was prepared by DMP oxidation of commercially available enantiopure 
alcohol 111 according to the known procedure (Scheme 46).55 Reaction of (+)-112 with 
the boron enolate of enantioenriched (-)-8ss (R = MOM) gave enantiopure 113 which was 
desulphurized by Raney Ni affording 114. The relative configurations of 113 and 114 are 
assigned based on the known configuration of stereogenic centre present in aldehyde 112 
and the numerous examples of aldol reactions of the boron enolate of 8ss to give 3,5-
trans-5,1"-anti adducts. Desulphurization of (+)-72f also produced 114. This result 
confirms the relative configuration of 72f by correlation to 114 (Scheme 46). The relative 
configuration of 73f was assigned based on analogy. 
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Scheme 46. Determination of the relative configuration of aldol adduct 72f and 73f. 
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3.  CONCLUSIONS 
The goal of this study was to expand the scope of aldol reactions with KR by 
designing new aldol reactions between the known ketone 8ss (R = MOM or TES) and 
newly designed aldehydes 7b-h. The diastereoselectivities of the aldol reactions can be 
predicted and rationalized by applying the multiplicativity rule to the three stereocontrol 
elements governing aldol couplings of chiral reactants. Considering the results of this 
study, designing new aldol reactions proceeding with KR is achieved by applying 
multiplicativity rule.  
Scheme 47. Summary of boron and titanium "ate" mediated aldol reactions of (±)-8ss (R 
= MOM or Et3Si) with the aldehydes (±)-7a-g. 
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Each of the stereocontrol elements (relative topicity of aldol coupling, aldehyde 
and enolate diastereoface selectivity) were strongly biased in the boron mediated aldol 
reaction of ketone 8ss and the aldehydes (±)-7a-g, thus the boron mediated aldol reactions 
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of these chiral reactants occurred with high MKE and high diastereoselectivity. However, 
titanium "ate" mediated aldol reactions of these reactants proceeded with moderate to 
good MKE. Further optimization of the titanium "ate" mediated aldol reactions condition 
might improve the selectivity of these reactions.  
Comparison of the results of current study with those reported for the boron and 
titanium "ate" mediated aldol reactions of aldehyde 7a shows that the aldol reactions of 
suitable enolates of 8 with aldehydes 7b-g should proceed with synthetically useful 
selectivity in KR. Some of the new aldol adducts synthesized in this project contain two 
different ketal protecting groups which decreases their symmetry. The two protected 
ketones can be potentially differentiated by selectively removing one or the other of the 
protecting groups using different conditions. This unique structural feature makes these 
adducts useful for future synthetic applications.   
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4. EXPERIMENTAL 
4.1.  General Methods 
All solvents were distilled prior to use.  Et3N and DIPEA were distilled from 
CaH2 and stored over KOH. Anhydrous solvents were distilled under argon atmosphere as 
follows:  Tetrahydrofuran (THF) from benzophenone potassium ketyl; CH2Cl2 from 
CaH2; acetonitrile (CH3CN) from CaH2 and stored over 4 Å molecular sieves; DMF over 
P2O5 and stored over 4 Å molecular sieves.  All experiments involving air- and/or 
moisture-sensitive compounds were conducted in an oven dried round-bottom flask 
capped with a rubber septum, and attached via a needle and connecting tubing to a 
mercury bubbler under argon atmosphere.  Low temperature baths were ice/water (0 °C), 
CO2(s)/CH3CN (-50 °C) and CO2(s)/acetone (-78 °C).  
Preparative TLC was carried out on glass plates (20 x 20 cm) pre-coated (0.25 
mm) with silica gel 60 F254.  Materials were detected by visualization under an 
ultraviolet lamp (254 nm).  Flash column chromatography (FCC) was performed with 
Merck Silica Gel 60 (40-63 mm).  All mixed solvents eluents are reported as v/v 
solutions. 
4.2.  Spectral Data 
High resolution mass spectra (HRMS) and low resolution mass spectra (LRMS) 
were obtained on a VG 70E double focussing high resolution spectrometer; only partial 
data are reported. Electron impact (EI) ionization was accomplished at 70 eV, chemical 
ionization (CI) at 50 eV with ammonia as the reagent gas, and fast-atom bombardment 
(FAB) in positive ion mode from a glycerol and methanol matrix. Infrared spectra were 
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recorded on a Biorad FTS-40 Fourier transform interferometer using a diffuse reflectance 
cell (DRIFT); only diagnostic peaks are reported. Unless otherwise noted, NMR spectra 
were measured in CDCl3 solution at 300 MHz for 1H and 75 MHz for 13C. Signals due to 
the solvent (13C NMR) or residual protonated solvent (1H NMR) served as the internal 
standard: CDCl3 (7.26 δH, 77.23 δC); C6D6 (7.16 δH, 128.39 δC). The 1H NMR chemical 
shifts and coupling constants were determined assuming first-order behavior. Multiplicity 
is indicated by one or more of the following: s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), br (broad), ap (apparent); the list of couplings constants (J) corresponds to 
the order of the multiplicity assignment. 1H NMR spectra were normally obtained with a 
digital resolution of 0.153 Hz/pt (sweep width = 10000 Hz, FID = 64 K data points) and 
coupling constants are reported to the nearest 0.5 Hz. The 1H NMR assignments were 
made on the basis of chemical shift, multiplicity, and consistency within a series of 
similar structures. The multiplicity of 13C NMR signals refers to the number of attached 
H's (i.e., s = C, d = CH, t = CH2, q = CH3) and was determined by DEPT-135. Optical 
rotations ([α]D) were determined at ambient temperature on a Perkin-Elmer 141 using a 1 
mL, 10 dm cell; the units are 10-1 deg cm2 g-1 and the concentrations (c) are reported in 
g/100 mL.  
4.3.  Materials 
NMR solvent CDCl3 was passed through basic Al2O3 before use. n-BuLi was 
titrated using diphenyl acetic acid as the titrant and indicator.  All other reagents were 
comercially available and, unless otherwise noted, were used as received. 
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4.4. Experimental procedures and spectral data  
1,4,8-Trithiaspiro[4.5]decane-6-carbaldehyde (7b) 
S
SS
7'
2' 3'
9'
10'
5'
6'
O
1
 
     7b 
IBX (4.7 g, 17 mmol) was added to a stirred solution of alcohol precursor 79 
(1.90 g, 8.56 mmol) in anhydrous DMSO (15 mL) at room temperature. After 1.5 h 
(reaction was complete by TLC analysis), the mixture was diluted with ethyl acetate (200 
mL) and washed sequentially with sat. NaHCO3, water, and brine. The organic layer was 
dried over Na2SO4, concentrated, and fractionated by FCC (50% ethyl acetate in hexane) 
to give the titled compound as a pale yellow oil (1.81 g, 96%). 
IR (DRIFT) νmax 1715 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 9.90 (1H, d, J = 0.7 Hz), 3.37-3.27 (4H, m), 2.97 (1H, 
ddd, J = 1.5, 3, 14 Hz), 2.91 (1H, dd, J = 3, 9 Hz), 2.86 (1H, ddd, J = 3, 10, 14 Hz), 2.74 
(1H, dd, J = 9, 14 Hz), 2.65 (1H, m, J = 1.5, 3, 6, 14 Hz), 2.43 (1H, ddd, J = 3, 6, 14 Hz), 
2.30 (1H, ddd, J = 3, 10, 14 Hz). 
13C NMR (125 MHz, CDCl3) δ: 201.5, 67.6, 58.4, 44.7, 39.7, 39.1, 29.4, 27.9. 
LRMS (EI), m/z (relative intensity): 220 ([M]+, 65), 192 (33), 164 (32), 136 (64), 99 
(100), 97 (26), 71 (77). 
HRMS m/z calcd. for C8H12OS3: 220.0050; found: 220.0047 (EI). 
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2-(2-Ethyl-1,3-dioxolan-2-yl)propanal (7c) 
OO
2 11''
2''
4' 5'
2'
O
  
      7c 
IBX (1.4 g, 5 mmol) was added to a stirred solution of alcohol 85 (396 mg, 2.47 
mmol) in anhydrous DMSO (5 mL) at room temperature. After 1.5 h (reaction was 
complete by TLC analysis), the mixture was diluted with diethyl ether (100 mL), and 
washed sequentially with sat. NaHCO3, water and brine. The organic layer was filtered 
through a short pad of silica gel and Na2SO4, and the combined filtrate and washings were 
concentrated to give the titled compound as a colorless oil (390 mg, 98%). 
IR (DRIFT) νmax 1725 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 9.75 (1H, d, J = 0.5 Hz), 4.01-3.93 (4H, m), 2.7-2.66 (1H, 
dq, J = 1.5, 7 Hz), 1.69 (1H, dq, J = 14.5, 7.5 Hz), 1.56 (1H, dq, J = 14.5, 7.5 Hz), 1.07 
(3H, d, J = 7 Hz), 0.87 (3H, t, J = 7.5 Hz). 
13
C NMR (125 MHz, CDCl3) δ: 203.7 (d), 112.0 (s), 65.6 (t), 65.5 (t), 52.9 (d), 28.9 (t), 
9.1 (q), 7.6 (q). 
HRMS m/z calcd. for C8H14O3+Na: 181.0835; found: 181.0837 (ESI). 
 
2-(2-Ethyl-1,3-dithian-2-yl)propanal (7e) 
SS
1
2
2'
4'
5'
6'
1''
2''
O
 
      7e 
IBX (3.1 g, 11 mmol) was added to a stirred solution of alcohol 87 (1.52 g, 7.4 
mmol) in anhydrous DMSO (37 mL) at room temperature. After 2 h (reaction was 
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complete by TLC analysis), the mixture was diluted with ethyl acetate (200 mL) and 
washed sequentially with sat. NaHCO3, water, and brine. The organic layer was dried 
over Na2SO4, concentrated, and fractionated by FCC (10% ethyl acetate in hexane) to 
give the titled compound (1.24 g, 83%). 
IR (DRIFT) νmax 1716, 2830, 2733 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 9.96 (1H, d, J = 2.5 Hz), 2.86-2.79 (5H, m), 2.12 (1H, dq, 
J = 7.5, 15 Hz), 2.01-1.89 (2H, m), 1.18 (3H, d, J = 7 Hz), 1.03 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 202.5 (s), 54.5 (s), 50.8 (d), 29.4 (t), 26.1 (t), 25.5 (t), 
24.9 (t), 9.7 (q), 9.4 (q). 
LRMS (EI), m/z (relative intensity): 204 ([M]+, 23), 175 (9), 147 (100), 107 (16), 102 
(20), 87 (7), 73 (28). 
HRMS m/z calcd. for C9H16OS2: 204.0643; found: 204.0650 (EI). 
 
2-(2-Methyl-1,3-dithiolan-2-yl)propanal (7f) 
SS
2 11''
4' 5'
2'
O
 
                                                                         7f 
IBX (1.8 g,6.5 mmol) was added to a stirred solution of alcohol 91 (583 mg, 3.27 
mmol) in anhydrous DMSO (8 mL) at room temperature. After 1.5 h (reaction was 
complete by TLC analysis), the mixture was diluted with ethyl acetate and washed 
sequentially with sat. NaHCO3, water and brine. The organic layer was dried over 
Na2SO4, concentrated, and fractionated by FCC (20% ethyl acetate in hexane) to give the 
titled compound (520 mg, 90%). 
IR (DRIFT) νmax 2832, 2726, 1721 cm
-1
. 
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1
H NMR (500 MHz, CDCl3) δ: 9.79 (1H, d, J = 2 Hz), 3.40-3.26 (4H, m), 2.76 (1H, dq, J 
= 2, 7 Hz), 1.75 (3H, s), 1.25 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 203.3 (s), 66.6 (s), 56.8 (d), 40.2 (t), 39.9 (t), 31.6 (q), 
13.2 (t). 
LRMS (EI), m/z (relative intensity): 176 ([M]+, 49), 133 (13), 121 (42), 119 (100), 88 
(53), 61 (45), 59 (64). 
HRMS m/z calcd. for C7H12OS2: 176.0330; found: 176.0335 (EI). 
 
2-(2-Methyl-1,3-dioxolan-2-yl)propanal (7g) 
OO
2 11''
4' 5'
2'
O
 
7g 
IBX (6.6 g, 23.6 mmol) was added to a stirred solution of alcohol 92 (1.72 g, 
11.8 mmol) in anhydrous DMSO (24 mL) at room temperature. After 1.5 h (reaction was 
complete by TLC analysis), the mixture was diluted with ether (200 mL) and washed 
sequentially with sat. NaHCO3, water and brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (40% ethyl acetate in hexane) to give the titled compound (1.56 g, 
92%). 
IR (DRIFT) νmax 1726 cm
-1
. 
1
H NMR ( MHz, ) δ: 9.75 (1H, d, J = 2 Hz), 4.0-3.94 (4H, m), 2.63 (1H, dq, J = 2, 7 Hz), 
1.29 (3H, s), 1.10 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 203.4 (d), 109.9 (s), 65.0 (t), 64.8 (t), 54.5 (d), 22.4 (q), 
9.3 (q). 
HRMS m/z calcd. for C7H12O3+Na: 167.0678; found: 167.0681 (ESI). 
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2-(1,3-Dithiolan-2-yl)butanal (7h) 
2'
4' 5'
SS O
1
2
3
4
 
  7h 
Prepared by adaptation of the published procedure.51 Oxalyl chloride (0.95 mL, 
1.4 g, 11 mmol) was added via syringe to a stirred solution of DMF (0.90 mL, 0.84 g, 
11.5 mmol) in CH2Cl2 (5 mL) at 0 °C under Ar in a two neck flask equipped with 
condenser. Upon addition of oxalyl chloride the mixture turned yellow. After stirring for 
30 min, a solution of 2-propyldithiolane 94 (680 mg, 4.59 mmol) in CH2Cl2 (5 mL) was 
added dropwise via syringe over 5 min. Anhydrous p-TSOH (79 mg, 0.46 mmol) was 
added and the mixture was heated under reflux. After 24 h (reaction complete by TLC 
analysis), the reaction was quenched by addition of ice water and the mixture was 
transferred to a separatory funnel with the aid of CH2Cl2. The organic phase was washed 
with sat. NaHCO3 and brine, dried over Na2SO4, concentrated, and fractionated by FCC 
(10% ethyl acetate in hexane) to give the titled compound (664 mg, 82%). 1H NMR data 
for 7h  were consistent with those previously reported. 
IR (DRIFT) νmax 2835, 2728, 1720 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 9.69 (1H, d, J = 2.5 Hz), 4.7 (1H, d, J = 7.5 Hz), 3.24-
3.17 (4H, m), 2.56-2.50 (1H, m), 1.83-1.69 (2H, m), 0.92 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 202.8 (s), 59.6 (s), 52.0 (d), 38.7 (t), 38.4 (t), 22.7 (t), 
11.4 (q). 
LRMS (EI), m/z (relative intensity): 176 ([M]+, 40), 143 (60), 115 (42), 105 (100). 
HRMS m/z calcd. for C7H12OS2: 176.0329; found: 176.0330 (EI). 
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(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(S)-(6S)-1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (72b (R = MOM)) 
S S
OO O OH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
MOM
S
SS
10"
9"
2"3"
 
72b (R = MOM) 
A solution of (±)-8ss (R = MOM) (141 mg, 0.40 mmol) in CH2Cl2 (2 mL; 0.2 M) 
was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M in 
CH2Cl2; 0.81 mL, 0.81 mmol) and Et3N (0.12 mL, 86 mg, 0.85 mmol) in CH2Cl2 (1 mL; 
5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7b (179 mg, 
0.81 mmol) in CH2Cl2 (1.4 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 
12 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 mL), 
MeOH (2 mL), and 30% aq H2O2 (1.0 mL). The mixture was stirred at 0 °C for 10 min 
and then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted 
with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated to 
give the crude product that 1H NMR indicated the presence of a 10:1 mixture of anti-
aldol and syn-aldol, respectively. Fractionation of the crude FCC (20-40% ethyl acetate in 
hexane) afforded recovered aldehyde (±)-7b (79 mg, 44%), a 2:1 mixture (by 1H NMR) 
of (±)-8ss (R = MOM) and syn-aldol (±)-73b (R = MOM) (35 mg), respectively, and the 
titled compound (156 mg, 69%). 
IR (DRIFT) νmax 3463, 1712 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.86 (1H, br dd, J = 5, 7 Hz), 4.70 (1H, d, J = 6 Hz), 4.66 
(1H, d, J = 6 Hz), 4.46 (1H, dd, J = 4.5, 5.5 Hz), 4.1-3.91 (4H, m), 3.42-3.22 (4H, m), 
3.37 (3H, s), 3.19-3.15 (1H, m), 3.03-2.89 (7H, m), 2.89-2.69 (6H, m), 2.50-2.46 (3H, m), 
2.28 (1H, ddd, J = 3, 12, 13.5 Hz), 2.13-2.06 (3H, m), 1.70 (1H, ddd, J = 3.5, 13, 13 Hz). 
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13C NMR (125 MHz, CDCl3) δ: 210.9 (s), 108.9 (s), 98.5 (t), 73.6 (s), 72.3 (d), 71.6 (d), 
64.7 (t), 64.6 (t), 57.6 (d), 56.8 (q), 56.1 (d), 51.6 (d), 49.2 (d), 47.2 (t), 39.7 (t), 39.3 (t), 
36.4 (t), 33.4 (t), 31.9 (t), 28.9 (t), 28.2 (t), 28.1 (t), 26.7 (t). 
LRMS (ESI), m/z (relative intensity): 591 ([M+23]+, 100), 371 (50). 
HRMS m/z calcd. for C23H36O6S5+Na: 591.1007; found: 591.0997 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(S)-(6S)-1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (72b (R = TES)) 
S S
OO O OH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
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S
SS
10"
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                                                                    72b (R = TES) 
A solution of (±)-8ss (R = TES) (29 mg, 0.069 mmol) in CH2Cl2 (0.4 mL; 0.2 M) 
was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M in 
CH2Cl2; 0.14 mL, 0.14 mmol) and Et3N (20 µL, 14 mg, 0.14 mmol) in CH2Cl2 (0.4 mL; 5 
mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7b (31 mg, 
0.14 mmol) in CH2Cl2 (0.2 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 
15 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 mL), 
MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 20 min and 
then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted with 
CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated to give 
the crude product whose 1H NMR spectrum indicated the presence of an 11:1 mixture of 
72b (R = TES) and 73b (R = TES), respectively. Fractionation of the crude by PTLC 
(10% ethyl acetate in hexane, multiple elution) afforded recovered aldehyde (±)-7b (12 
mg, 39%), syn-aldol 73b (R = TES) (3mg, 7%) and the titled compound (31mg, 70%). 
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IR (DRIFT) νmax 3467, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.06 (1H, br dd, J = 3, 8 Hz), 4.65 (1H, dd, J = 2, 7.5 Hz), 
4.02-3.82 (4H, m), 3.44-3.24 (4H, m), 3.21-3.18 (1H, m), 3.06-2.93 (4H, m), 2.87-2.68 
(8H, m), 2.56 (1H, br d, J = 14 Hz), 2.51-2.46 (2H, m), 2.29 (1H, ddd, J = 3, 12, 13.5 Hz), 
2.11-1.99 (3H, m), 1.68 (1H, ddd, J = 4, 12, 13.5 Hz), 0.93 (9H, t, J = 8 Hz), 0.67-0.60 
(6H, m). 
13C NMR (125 MHz, CDCl3) δ: 209.1 (s), 109.5 (s), 73.4 (s), 71.2 (d), 66.4 (d), 64.84 (t), 
64.82 (t), 58.4 (d), 55.6 (d), 51.9 (d), 49.8 (d), 47.3 (t), 39.8 (t), 39.5 (t), 37.1 (t), 32.7 (t), 
29.8 (t), 29.2 (t), 28.7 (t), 28.3 (t), 26.7 (t), 7.4 (q ×3), 5.4 (t ×3). 
LRMS (ESI), m/z (relative intensity): 661 ([M+23]+, 70), 468 (100), 296 (30), 206 (20). 
HRMS m/z calcd. for C27H46O5SiS5+Na: 661.1610; found: 661.1623 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1R,2R)-2-(2-ethyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (72c (R = MOM)) 
  
S S
OO O OOOH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
2'''
4'''5'''
1''''
2''''
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 72c (R = MOM) 
A solution of (±)-8ss (R = MOM) (135 mg, 0.387 mmol) in CH2Cl2 (2 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.77 mL, 0.77 mmol) and Et3N (0.11 mL, 82 mg, 0.81 mmol) in CH2Cl2 (2 
mL) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7c (122 mg, 0.77 mmol) in 
CH2Cl2 (0.5 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 3 h, the reaction 
was quenched by sequential addition of phosphate buffer (pH 7; 7 mL), MeOH (7 mL), 
and 30% aq H2O2 (4 mL). The mixture was stirred at 0 °C for 10 min and then was 
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diluted with ice-water and saturated aq Na2SO3 (ca. 15 mL) and extracted with CH2Cl2. 
The combined organic layers were dried over Na2SO4 and concentrated to give the crude 
product whose 1H NMR spectrum indicated the presence of a single aldol adduct (>20:1). 
Fractionation of the crude FCC (15-90% ethyl acetate in hexane followed by 20% 
methanol in dichloromethane) afforded recovered aldehyde (±)-7c (7 mg, 6%), (±)-8ss (R 
= MOM) (2 mg, 1%), and the titled compound (162 mg. 83%). 
IR (DRIFT) νmax 3521, 1712 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.69 (1H, br d, J = 9.5 Hz), 4.67 (1H, d, J = 6 Hz), 4.65 
(1H, d, J = 6 Hz), 4.38 (1H, dd, J = 5, 5 Hz), 4.01-3.90 (8H, m), 3.35 (3H, s), 3.31 (1H, 
ddd, J = 4.5, 5, 10 Hz), 3.03-2.94 (1H, m), 2.91 (1H, d, J = 2 Hz), 2.83-2.75 (1H, m), 2.58 
(1H, ddd, J = 2, 5, 14 Hz), 2.48-2.45 (1H, m), 2.11 (1H, ddd, J = 4.5, 5, 10 Hz), 2.04 (1H, 
ddd, J = 3, 4.5, 13.5 Hz), 1.91 (1H, br q, J = 7, 14 Hz), 1.80-1.69 (2H, m), 1.66 (1H, ddd, 
J = 3.5, 12.5. 13.5 Hz), 0.93 (3H, , J = 7 Hz), 0.89 (3H, , J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 210.7 (s), 114.5 (s), 109.0 (s), 98.7 (t), 72.9 (d), 69.3 (d), 
65.8 (t), 65.1 (t), 64.7 (t), 64.5 (t), 56.8 (d), 56.6 (q), 54.9 (d), 49.0 (d), 39.3 (d), 36.4 (t), 
32.5 (t), 31.5 (t), 28.4 (t), 28.3 (t), 26.7 (t), 8.2 (q), 7.0 (q). 
HRMS m/z calcd. for C23H38O8S2+Na: 529.1900; found: 529.1898 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1R,2R)-2-(2-ethyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (72c (R = TES)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
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2'''
4'''5'''
1''''
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OO
2''''
 
                                                                     72c (R = TES) 
A solution of (±)-8ss (R = TES) (37 mg, 0.088 mmol) in CH2Cl2 (0.4 mL; 0.2 M) 
was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M in 
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CH2Cl2; 0.18 mL, 0.18 mmol) and Et3N (25 µL, 18 mg, 0.18 mmol) in CH2Cl2 (0.4 mL; 5 
mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7c (28 mg, 
0.18 mmol) in CH2Cl2 (0.3 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 3 
h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 mL), 
MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 min and 
then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted with 
CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated to give 
the crude product whose 1H NMR spectrum indicated the presence of a single bisaldol 
adduct (dr >20). Fractionation of the crude by FCC (25% ethyl acetate in hexane) 
afforded recovered aldehyde (±)-7c (7 mg, 25%) and the titled compound (39 mg, 76%). 
IR (DRIFT) νmax 3518, 1711 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.80 (1H, br d, J = 10 Hz), 4.62 (1H, dd, J = 1.5, 8 Hz), 
4.03-3.85 (8H, m), 3.37 (1H, ddd, J = 1.5, 5, 11.5 Hz), 3.04 (1H, dd, J = 11.5, 13.5 Hz), 
2.98 (1H, dd, J = 3.5, 14 Hz), 2.89 (1H, br s), 2.87 (1H, ddd, J = 3, 4.5, 13.5 Hz), 2.81 
(1H, ddd, J = 3, 13, 13.5 Hz), 2.77-2.63 (3H, m), 2.61 (1H, ddd, J = 3, 3, 14 Hz), 2.48 
(1H, br d, J = 13.5 Hz), 2.10 (1H, ddd, J = 4, 8, 11 Hz), 2.04-1.95 (2H, m), 0.96-0.90 
(15H, m), 0.69-0.60 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 209.5 (s), 114.7 (s), 109.5 (s), 69.5 (d), 66.6 (d), 65.9 (t), 
65.2 (t), 65.0 (t), 64.8 (t), 57.2 (d), 54.9 (d), 49.7 (d), 39.1 (d), 37.2 (t), 32.2 (t), 29.8 (t), 
29.2 (t), 28.5 (t), 26.6 (t), 8.3 (q), 7.3 (q ×3), 6.7 (q), 5.3 (q ×3). 
LRMS (ESI), m/z (relative intensity): 599 ([M+23]+, 100), 279 (80). 
HRMS m/z calcd. for C27H48O7SiS2+Na: 599.2502; found: 599.2485 (ESI). 
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(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1S,2R)-2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (72d (R = MOM)) 
S S
OO O OH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
MOM
SS 2"'
1''''
2''''
4"'5"'
 
72d (R = MOM) 
A solution of (±)-8ss (R = MOM) (84 mg, 0.24 mmol) in CH2Cl2 (1.2 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.48 mL, 0.48 mmol) and Et3N (70 µL, 51 mg, 0.50 mmol) in CH2Cl2 (1.2 
mL; 5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7d (91 
mg, 0.48 mmol) in CH2Cl2 (0.8 mL; 0.6 M) was added slowly via syringe (ca. 5 min). 
After 3 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 6 
mL), MeOH (6 mL), and 30% aq H2O2 (3 mL). The mixture was stirred at 0 °C for 10 
min and then was diluted with ice-water and saturated aq Na2SO3 (ca. 15 mL) and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated to give the crude product whose 1H NMR indicated the presence of a 17:1 
mixture of 72d (R = MOM)  and 73d (R = MOM), respectively. Fractionation of the 
crude FCC (30-40% ethyl acetate in hexane) afforded recovered aldehyde (±)-7d (21 mg, 
23%), (±)-8ss (R = MOM) (10 mg, 11%), syn-aldol (±)-73d (R = MOM)  (6 mg, 5%) and 
the titled compound (102 mg 79%). 
IR (DRIFT) νmax 3508, 1707 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.80 (1H, dd, J = 3, 9 Hz), 4.67 (1H, d, J = 6 Hz), 4.65 
(1H, d, J = 6 Hz), 4.42 (1H, dd, J = 5, 5 Hz), 4.04-3.90 (4H,), 3.35 (3H, s), 3.32-3.20 (5H, 
m), 3.06-2.92 (4H, m), 2.85-2.73 (4H, m), 2.67 (1H, dd, J = 5.5, 13.5 Hz), 2.48 (1H, br d, 
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J = 13.5 Hz), 2.12-1.95 (5H, m), 1.69-1.63 (1H, ddd, J = 3.5, 12.5, 13.5 Hz), 1.09 (3H, d, 
J = 7 Hz), 1.06 (3H, t, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 211.1 (s), 109.0 (t), 98.7 (t), 77.8 (s), 72.8 (d), 71.0 (d), 
64.6 (t), 64.5 (t), 57.3 (d), 56.7 (q), 55.8 (d), 49.0 (d), 44.4 (d), 40.4 (t), 39.8 (t), 36.2 (t), 
35.9 (t), 32.5 (t), 31.3 (t), 28.3 (t), 26.7 (t), 11.3 (q), 10.8 (q). 
LRMS (ESI), m/z (relative intensity): 561 ([M+23]+, 100), 529 (10), 507 (40), 475 (5). 
HRMS m/z calcd. for C23H38O6S4+Na: 561.1443; found: 561.1460 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1S,2R)-2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (72d (R = TES)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
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72d (R = TES) 
A solution of (±)-8ss (R = TES) (33 mg, 0.079 mmol) in CH2Cl2 (0.4 mL; 0.2 M) 
was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M in 
CH2Cl2; 0.16 mL, 0.16 mmol) and Et3N (24 µL, 17 mg, 0.17 mmol) in CH2Cl2 (0.4 mL; 5 
mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7d (30 mg, 
0.16 mmol) in CH2Cl2 (0.3 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 
16 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 mL), 
MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 min and 
then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted with 
CH2Cl2 (3 times). The combined organic layers were dried over Na2SO4 and concentrated 
to give the crude product whose 1H NMR spectrum indicated the presence of a >20:1 
mixture of 72d (R = TES) and 73d (R = TES), respectively. Fractionation of the crude by 
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PTLC (10% ethyl acetate in hexane, 2 elutions) afforded recovered aldehyde (±)-7d (10 
mg, 33%), (±)-8ss (R = TES) (2 mg, 6%), and the titled compound (36 mg, 75%). 
IR (DRIFT) νmax 3500, 1708 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.97 (1H, dd, J = 3, 9 Hz), 4.64 (1H, dd, J = 1.5, 7.5 Hz), 
3.99-3.82 (4H, m), 3.38-3.25 (5H, m), 3.03 (1H, dd, J = 11.5, 13.5 Hz), 2.98 (1H, dd, J = 
3, 13.5 Hz), 2.93 (2H, m, J = 3 Hz), 2.87 (4H, m, J = 2.5, 4.5, 13.5 Hz), 2.81 (1H, ddd, J 
= 2.5, 12.5, 13.5 Hz), 2.78-2.62 (4H, m), 2.48 (1H, br d, J = 13.5 Hz), 2.09 (1H, ddd, J = 
4, 7.5, 11 Hz), 2.08-1.95 (3H, m), 1.67 (1H, ddd), 1.09 (3H, d, J = 7 Hz), 1.08 (3H, t, J = 
7 Hz), 0.94 (9H, t, J = 8 Hz), 0.71-0.59 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 209.7 (s), 109.5 (s), 77.7 (s), 71.1 (d), 66.6 (d), 64.9 (t), 
64.7 (t), 58.1 (d), 55.9 (d), 49.6 (d), 44.5 (d), 40.5 (t), 39.9 (t), 37.0 (t), 36.5 (t), 32.2 (t), 
29.6 (t), 29.2 (t), 26.7 (t), 11.4 (q), 10.9 (q), 7.3 (q ×3), 5.3 (t ×3). 
LRMS (ESI), m/z (relative intensity): 631 ([M+23]+, 30), 468 (15), 296 (15), 229 (100), 
206 (20). 
HRMS m/z calcd. for C27H48O5SiS4+Na: 631.2046; found: 631.2023 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1S,2R)-2-(2-ethyl-1,3-dithian-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (72e (R = MOM)) 
S S
OO O OH
2' 3'
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                                                            72e (R = MOM) 
A solution of (±)-8ss (R = MOM) (24 mg, 0.069 mmol) in CH2Cl2 (0.3 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.14 mL, 0.14 mmol) and Et3N (20 µL, 14 mg, 0.14 mmol) in CH2Cl2 (0.3 
mL; 5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7e (29 
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mg, 0.14 mmol) in CH2Cl2 (0.2 mL; 0.6 M) was added slowly via syringe (ca. 5 min). 
After 3 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 
mL), MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 
min and then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated to give the crude product whose 1H NMR indicated the presence of a single 
adduct (dr >20). Fractionation of the crude by FCC (30% ethyl acetate in hexane) 
afforded recovered (±)-7e (8 mg, 27%), (±)-8ss (R = MOM) (2 mg, 8%), and the titled 
compound (34 mg, 89%). 
IR (DRIFT) νmax 3500, 1706 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.04 (1H, dd, J = 4.5, 9 Hz), 4.69 (1H, d, J = 6 Hz), 4.67 
(1H, d, J = 6 Hz), 4.46 (4H, dd, J = 5, 5 Hz), 4.06-3.93 (4H, m), 3.36 (3H, s), 3.25 (1H, 
ddd, J = 4.5, 5, 9.5 Hz), 3.11-2.64 (12H, m), 2.70 (1H, d, J = 4.5 Hz), 2.50 (1H, br d, J = 
13 Hz), 2.29 (1H, dq, J = 7.5, 15 Hz), 2.11-1.97 (4H, m), 1.93-1.85 (2H, m), 1.68 (1H, 
ddd, J = 3.5, 12, 13.5 Hz), 1.09 (3H, d, J = 7 Hz), 0.99 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 211.2 (s), 108.9 (s), 98.6 (t), 72.7 (d), 70.2 (d), 64.6 (t), 
64.6 (t), 59.4 (s), 57.4 (d), 56.8 (q), 55.9 (d), 49.1 (d), 41.3 (d), 36.2 (t), 32.9 (t), 31.5 (t), 
29.2 (t), 28.4 (t), 26.7 (t), 26.1 (t), 25.9 (t), 25.2 (t), 9.6 (q), 7.6 (q). 
HRMS m/z calcd. for C24H40O6S4+Na: 575.1599 ; found: 575.1600 (ESI). 
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(3R,5R)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-5-
[(1S,2R)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (72f (R = MOM)) 
S S
OO O OH
2' 3'
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                                                          72f (R = MOM) 
A solution of (+)-8ss (R = MOM) (31 mg, 0.089 mmol) in CH2Cl2 (0.4 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.18 mL, 0.18 mmol) and Et3N (26 µL, 19 mg, 0.19 mmol) in CH2Cl2 (0.4 
mL; 5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7f (48 
mg, 0.27 mmol) in CH2Cl2 (0.4 mL; 0.6 M) was added slowly via syringe (ca. 5 min). 
After 3 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 
mL), MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 
min and then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated to give the crude product whose 1H NMR spectrum indicated the presence of 
a single bisaldol adduct. Fractionation of the crude by FCC (10-50 % ethyl acetate in 
hexane) afforded recovered aldehyde (±)-7f (21 mg, 43%) and the titled compound (38 
mg, 81%) ([α]D +120; c 2.5, CHCl3).  
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 (3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6yl(methoxymethoxy)methyl] 
-5-[(1S,2R)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-
thiopyran-4-one (72f (R = MOM)) 
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                                                           72f (R = MOM) 
A solution of (±)-8ss (R = MOM) (45 mg, 0.13 mmol) in CH2Cl2 (0.7 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.26 mL, 0.26 mmol) and Et3N (38 µL, 27 mg, 0.27 mmol) in CH2Cl2 (0.7 
mL; 5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7f (46 
mg, 0.26 mmol) in CH2Cl2 (0.4 mL; 0.6 M) was added slowly via syringe (ca. 5 min). 
After 3 h, the reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 
mL), MeOH (2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 
min and then was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and 
concentrated to give the crude product whose 1H NMR spectrum indicated the presence of 
a single bisaldol adduct. Fractionation of the crude by FCC (30-50 % ethyl acetate in 
hexane) afforded recovered aldehyde (±)-7f (18 mg, 39%) and the titled compound (45 
mg, 66%). 
IR (DRIFT) νmax 3512, 1704 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70-4.63 (3H, m), 4.49 (1H, dd, J = 5, 5.5 Hz), 4.08-3.91 
(4H, m), 3.38-3.24 (4H, m), 3.36 (3H, s), 3.17 (1H, ddd, J = 4, 5.5, 9 Hz), 3.10 (1H, dd, J 
= 9, 13.5 Hz), 3.02-2.94 (1H, m), 2.92 (1H, d, J = 4 Hz), 2.90-2.65 (5H, m, J = 7 Hz), 
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2.50 (1H, br d, J = 13.5 Hz), 2.10-2.07 (2H, m), 2.00 (1H, br q, J = 7 Hz), 1.83 (3H, s), 
1.67 (1H, ddd, J = 3.5, 12, 13.5 Hz), 1.15 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 212.1 (s), 108.9 (s), 98.6 (t), 72.9 (d), 72.3 (s), 71.8 (d), 
64.7 (t), 64.6 (t), 57.8 (d), 56.8 (q), 55.4 (d), 49.0 (d), 46.9 (d), 40.1 (t), 39.7 (t), 36.2 (t), 
32.2 (t), 31.8 (q), 31.2 (t), 28.3 (t), 26.7 (t), 11.5 (q). 
LRMS (ESI), m/z (relative intensity): 547 (100), 493 (10), 371 (20), 275 (5), 130 (40). 
HRMS m/z calcd. for C22H36O6S4+Na: 547.1286; found: 547.1298 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1S,2R)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (72f (R = TES)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
TES
2'''
4'''5'''
1''''
2"
3"
SS
 
                                                             72f (R = TES) 
A solution of (±)-8ss (R = TES) (25 mg, 0.060 mmol) in CH2Cl2 (0.3 mL; 0.2 M) 
was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M in 
CH2Cl2; 0.12 mL, 0.12 mmol) and Et3N (18 µL, 13 mg, 0.13 mmol) in CH2Cl2 (0.3 mL; 5 
mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7f (21 mg, 0.12 
mmol) in CH2Cl2 (0.2 mL; 0.6 M) was added slowly via syringe (ca. 5 min). After 3 h, the 
reaction was quenched by sequential addition of phosphate buffer (pH 7; 2 mL), MeOH 
(2 mL), and 30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 min and then 
was diluted with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted with 
CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated to give 
the crude product whose 1H NMR spectrum indicated the presence of a single bisaldol (dr 
>20), unreacted 8ss (R = TES) and aldehyde 7f. Fractionation of the crude by PTLC (10% 
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ethyl acetate in hexane, multiple elution) afforded recovered aldehyde (±)-7f (9 mg, 
43%), (±)-8ss (R = TES) (2 mg, 8%), and the titled compound (27 mg, 75%). 
IR (DRIFT) νmax 3500, 1706 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.85 (1H, dd, J = 4, 9 Hz), 4.65 (1H, br d, J = 7 Hz), 
4.01-3.85 (4H, m), 3.39-3.27 (4H, m), 3.23 (1H, br dd, J = 3.5, 9 Hz), 3.06-2.95 (2H, m), 
2.87 (1H, dd, J = 3.5, 13.5 Hz), 2.80 (1H, ddd, J = 2, 12.5, 13.5 Hz), 2.76 (1H, d, J = 4 
Hz), 2.75-2.65 (4H, m), 2.48 (1H, br d, J = 13.5 Hz), 2.09-1.96 (3H, m), 1.83 (3H, s), 
1.66 (1H, ddd, J = 3.5, 12.5, 13.5 Hz), 1.13 (3H, d, J = 7 Hz), 0.93 (9H, t, J = 8 Hz), 0.66-
0.60 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 210.6 (s), 109.5 (s), 72.1 (d), 71.8 (s), 66.6 (d), 64.8 (t), 
64.7 (t), 58.3 (d), 55.7 (d), 49.7 (d), 47.0 (d), 40.1 (t), 39.9 (t), 36.9 (t), 32.4 (q), 31.8 (t), 
29.3 (t), 29.1 (t), 26.7 (t), 11.4 (q), 7.3 (q ×3), 5.4 (t ×3). 
LRMS (ESI), m/z (relative intensity): 617 ([M+23]+, 100), 463 (5), 297 (5). 
HRMS m/z calcd. for C26H46O5SiS4+Na: 617.1889; found: 617.1900 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1R,2R)-2-(2-methyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-
thiopyran-4-one (72g (R = MOM)) 
S S
OO O OOOH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
2'''
4'''5'''
1''''
MOM
  
72g (R = MOM) 
A solution of (±)-8ss (R = MOM) (23 mg, 0.066 mmol) in CH2Cl2 (0.3 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.13 mL, 0.13 mmol) and Et3N (20 µL, 14 mg, 0.14 mmol) in CH2Cl2 (0.3 
mL) at -78 °C under Ar. After 2 h, a solution of aldehyde (±)-7g (19 mg, 0.13 mmol) in 
CH2Cl2 (0.15 mL) was added slowly via syringe (ca. 5 min). After 3 h, the reaction was 
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quenched by sequential addition of phosphate buffer (pH 7; 2 mL), MeOH (2 mL), and 
30% aq H2O2 (1 mL). The mixture was stirred at 0 °C for 10 min and then was diluted 
with ice-water and saturated aq Na2SO3 (ca. 5 mL) and extracted with CH2Cl2. The 
combined organic layers were dried over Na2SO4 and concentrated to the crude product 
whose 1H NMR spectrum indicated the presence of a single aldol adduct. Fractionation of 
the crude by FCC (30% ethyl acetate in hexane) afforded recovered aldehyde (±)-7g (3 
mg, 16%), (±)-8ss (R = MOM) (2 mg, 9%), and the titled compound (25 mg, 78%). 
IR (DRIFT) νmax 3524, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70-4.64 (3H, m), 4.43 (1H, dd, J = 5, 5 Hz), 4.05-3.90 
(8H, m), 3.36 (3H, s), 3.27 (1H, ddd, J = 4, 5, 9.5 Hz), 3.06 (1H, dd, J = 10, 13.5 Hz), 
2.99-2.94 (2H, m), 2.87-2.75 (5H, m), 2.61 (1H, ddd, J = 1.5, 6, 13.5 Hz), 2.49 (1H, br d, 
J = 13.5 Hz), 2.10 (1H, ddd, J = 4, 5, 10.5 Hz), 2.06 (1H, ddd, J = 3, 4.5, 13.5 Hz), 1.82 
(1H, br q, J = 7 Hz), 1.67 (1H, ddd, J = 3.5, 12.5, 13.5 Hz), 1.37 (3H, s), 0.98 (3H, d, J = 
7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 211.1 (s), 112.5 (s), 109.0 (s), 98.7 (t), 73 (d), 69.4 (d), 
65.1 (t), 64.7 (t), 64.64 (t), 64.57 (t), 57 (d), 56.8 (q), 54.8 (d), 49.1 (d), 42.4 (d), 36.4 (t), 
32.3 (t), 31.3 (t), 28.4 (t), 26.7 (t), 22.4 (q), 7.5 (q). 
HRMS m/z calcd. for C22H36O8S2+Na: 515.1743; found: 515.1761 (ESI). 
 
  
(3S,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxmethyl]-5-[(S)-(6S)-
1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (73b R 
= MOM)) 
S S
OO O OH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
MOM
S
SS
10"
9"
2"3"
 
                                                           73b (R = MOM) 
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A solution of freshly prepared LDA (0.5 M in THF; 0.34 mL, 0.17 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (51 mg, 0.15 mmol) 
in THF (1.5 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.20 mL, 190 mg, 
0.66 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -
50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7b 
(66 mg, 0.30 mmol) in THF (0.4 mL, 0.8 M) was added via syringe. After 1 h, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The organic layers were filtered through a short column layered with 
Na2SO4, SiO2, and Na2SO4 and the combined filtrates and washings were concentrated to 
give the crude product whose 1H NMR spectrum indicated the presence of a 13:1 mixture 
of 73b (R = MOM) and 72b (R = MOM), respectively [note: 1H NMR of the crude from 
a similar experiment using 2.2 equiv of Ti(OiPr)4 showed a 9:1 mixture of 73b (R = 
MOM) and 72b (R = MOM), respectively. Fractionation of the crude by FCC (20-40% 
ethyl acetate in hexane) afforded recovered aldehyde (±)-7b (22 mg, 33%), (±)-8ss (R = 
MOM) (2 mg, 4%), anti aldol (±)-72b (R = MOM) (5 mg, 6%) and the titled compound 
(62 mg, 73%). 
IR (DRIFT ) νmax 3453, 1699 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.11 (1H, br dd, J = 2, 9 Hz), 4.69 (1H, d, J = 6 Hz), 4.63 
(1H, d, J = 6 Hz), 4.59 (1H, dd, J = 3, 6.5 Hz), 4.10-43.92 (4H, m), 3.50 (1H, d, J = 2 
Hz), 3.39-3.28 (4H, m), 3.37 (3H, s), 3.18 (1H, br dd, J = 3.5, 13.5 Hz), 3.10-2.92 (6H, 
m), 2.88 (1H, dd, J = 11.5, 13.5 Hz), 2.82 (1H, ddd, J = 3, 13, 13 Hz), 2.78-2.68 (3H, m), 
2.58-2.35 (4H, m), 2.08 (1H, ddd, J = 4.9, 8.8 Hz), 2.01 (1H, dd), 1.92 (1H, ddd, J = 3, 
3.5, 11.5 Hz), 1.77 (1H, ddd, J =                       4, 13, 13 Hz) . 
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13C NMR (125 MHz, CDCl3) δ: 210.5 (s), 108.9 (s), 98.5 (t), 73.8 (s), 71.7 (d), 69.5 (d), 
64.8 (t), 64.5 (t), 58.3 (d), 56.8 (q), 55.7 (d), 50.1 (d), 49.9 (d), 47.3 (t), 39.5 (t), 39.4 (t), 
36.2 (t), 33.8 (t), 32.8 (t), 28.15 (t), 28.07 (t), 28.05 (t), 26.8 (t). 
LRMS (ESI), m/z (relative intensity): 591 ([M+23]+, 100), 537 (33), 371 (15), 317 (7). 
HRMS m/z calcd. for C23H36O6S5+Na: 591.1007; found: 591.1015 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(R)-(6R)-1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (73b (R = TES)) 
S S
OO O OH
2' 3'
7''
6''1''
6
5
2
31'6'
7'9'
10'
O
TES
S
SS
10"
9"
2"3"
 
                                                              73b (R = TES) 
A solution of freshly prepared LDA (0.5 M in THF; 0.2 mL, 0.1 mmol,) at 0 °C 
was added via syringe to a stirred solution of (±)-8ss (R = TES) (37 mg, 0.088 mmol) in 
THF (0.9 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (57 µL, 54 mg, 0.19 
mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -50°C 
(CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7b (40 mg, 
0.18 mmol) in THF (0.2 mL, 0.8 M) was added via syringe. After 16 h, the reaction was 
quenched by addition of saturated aq NH4Cl and the mixture was extracted with ethyl 
acetate. The organic layers were filtered through a short column layered with Na2SO4, 
SiO2, and Na2SO4 and the combined filtrates and washings were concentrated to give the 
crude product whose 1H NMR spectrum indicated the presence of a 2:1 mixture of 73b (R 
= TES)  and 72b (R = TES), respectively. Fractionation of the crude by PTLC (10% ethyl 
acetate in hexane, multiple elution) afforded recovered aldehyde (±)-7b (10 mg, 25%), 
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(±)-8ss (R = TES) (6 mg, 23%), anti aldol 72b (R = TES) (11 mg, 20%), and the titled 
compound (26 mg, 46%) 
IR (DRIFT) νmax 3448, 1698 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 2.26 (1H, br d, J = 10 Hz), 4.74 (1H, br s), 4.07-3.89 (4H, 
m), 3.50 (1H, br s), 3.42-3.23 (4H, m), 3.12 (1H, br d, J = 13.5 Hz), 3.05-2.73 (10H, m), 
2.67 (1H, br d, J = 13.5 Hz), 2.55 (1H, br d, J = 14 Hz), 2.49-2.43 (2H, m), 2.31 (1H, ddd, 
J = 2.5, 12, 13.5 Hz), 2.05-2.00 (2H, m), 1.94 (1H, dd, J = 6.5, 7 Hz), 1.69 (, ddd, J = 3.5, 
13, 13.5 Hz), 0.94 (9H, t, J = 8 Hz), 0.68-0.57 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 209.9 (s), 109.6 (s), 73.6 (s), 69.4 (d), 65.4 (d), 65.1 (t), 
64.4 (t), 59.9 (d), 55.9 (d), 51.0 (d), 49.4 (d), 47.0 (t), 39.7 (t), 39.5 (t), 36.3 (t), 33.0 (t), 
30.7 (t), 28.8 (t), 28.2 (t), 28.0 (t), 26.6 (t), 7.3 (q ×3), 5.3 (t ×3). 
LRMS (ESI), m/z (relative intensity): 661 ([M+23]+, 70), 468 (100), 296 (40), 206 (30). 
HRMS m/z calcd. for C27H46O5SiS5+Na: 661.1610; found: 661.1604 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1S,2S)-2-(2-ethyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (73c (R = MOM)) 
 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
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OO 2'''
4'''5'''
1''''
2''''
2"
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                                                              73c (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.60 mL, 0.30 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (95 mg, 0.27 mmol) 
in THF (2.7 mL; 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.18 mL, 168 mg, 
0.59 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -
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50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7c 
(85 mg, 0.54 mmol) in THF (0.7 mL, 0.8 M) was added via syringe. After 30 min, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The combined organic layers were filtered through a short column 
layered with Na2SO4, SiO2, and Na2SO4 and the combined filtrate and ethyl acetate 
washings were concentrated to give the crude product whose 1H NMR indicated the 
presence of a 4:1 mixture of syn-aldol, anti-aldol, respectively. Fractionation of the crude 
by FCC (30-50% ethyl acetate in hexane) afforded recovered aldehyde (±)-7c (20 mg, 
24%), (±)-8ss (R = MOM) (9 mg, 9%), anti-aldol (±)-72c (R = MOM) (26 mg, 19%), and 
the titled compound (95 mg. 69%). 
IR (DRIFT) νmax 3515, 1700 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.66 (1H, d, J = 6 Hz), 4.63 (1H, d, J = 6 Hz), 4.55 (1H, 
br d, J = 9.5 Hz), 4.53 (1H, dd, J = 4.5, 5.5 Hz), 4.04-3.90 (8H, m), 3.35 (3H, s), 3.16-
3.06 (2H, m), 3.12 (1H, br d), 3.03-2.88 (4H, m), 2.84 (1H, dd, J = 11, 14 Hz), 2.82-2.70 
(2H, v), 2.49 (1H, br d, J = 13.5 Hz), 2.05 (1H, ddd, J = 3, 4.5, 13.5 Hz), 1.91 (1H, ddd, J 
= 3.5, 4, 11 Hz), 1.82 (1H, dq, J = 1, 7 Hz), 1.73-1.65 (2H, m), 1.60 (1H, ddd, J = 3.5,12, 
13.5 Hz), 0.96 (3H, d, J = 7 Hz), 0.89 (3H, T, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 210.6 (s), 114.9 (s), 108.8 (s), 98.6 (t), 72.3 (d), 67.8 (d), 
65.6 (t), 65.2 (t), 64.61 (t), 64.55 (t), 56.8 (q), 56.7 (d), 55.1 (d), 49.2 (d), 39.8 (d), 36.1 
(t), 32.8 (t), 31.8 (t), 28.2 (t), 28.1 (t), 26.7 (t), 8.2 (q), 7.6 (q). 
HRMS m/z calcd. for C23H38O8S2+Na: 529.1900; found: 529.1912 (ESI). 
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(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1S,2S)-2-(2-ethyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (73c (R = TES)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
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2'''
4'''5'''
1''''
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                                                              73c (R = TES) 
A solution of freshly prepared LDA (0.5 M in THF; 0.12 mL, 0.06 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = TES) (22 mg, 0.053 mmol) 
in THF (0.5 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (36 µL, 34 mg, 0.12 
mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -50°C 
(CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7c (17 mg, 
0.11 mmol) in THF (0.14 mL, 0.8 M) was added via syringe. After 15 h, the reaction was 
quenched by addition of saturated aq NH4Cl and the mixture was extracted with ethyl 
acetate. The organic layers were filtered through a short column layered with Na2SO4, 
SiO2, and Na2SO4 and the combined filtrates and ethyl acetate washings were 
concentrated to give the crude product whose 1H NMR spectrum indicated the presence of 
a 3:1 mixture of anti-aldol 72c (R = TES) and the titled compound, respectively. 
Fractionation of the crude by PTLC (25% ethyl acetate in hexane) afforded recovered 
aldehyde (±)-7c (2 mg, 12%), (±)-8ss (R = TES) (3 mg, 14%), anti-aldol (±)-72c (R = 
TES) (21 mg, 68%), and the titled compound (5 mg, 16%). 
IR (DRIFT) νmax 3515, 1700 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.71-4.66 (2H, m), 4.08-3.79 (8H, m), 3.18 (1H, br s), 
3.13 (1H, ddd, J = 2, 4.5, 3.5 Hz), 3.08-2.98 (2H, m), 2.88-2.74 (4H, m), 2.73-2.68 (2H, 
m), 2.52-2.47 (1H, ddd, J = 3.5, 4, 13.5 Hz), 2.03-1.97 (2H, m), 1.79-1.66 (3H, m), 1.61 
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(1H, ddd, J = 3.5, 12, 13.5 Hz), 0.98 (3H, d, J = 7 Hz), 0.94 (9H, t, J = 8 Hz), 0.88 (3H, t, 
J = 7.5 Hz), 0.69-0.57 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 210.0 (s), 114.9 (s), 109.4 (s), 67.5 (d), 66.1 (d), 65.9 (t), 
65.3 (t), 64.6 (t), 64.5 (t), 59.2 (d), 55.4 (d), 49.7 (d), 40.1 (d), 36.4 (t), 32.0 (t), 29.8 (t), 
29.0 (t), 28.5 (t), 26.7 (t), 8.3 (q), 7.45 (q), 7.34 (q ×3), 5.4 (q ×3). 
 (ESI), m/z (relative intensity):. 
HRMS m/z calcd. for C27H48O7SiS2+Na: 599.2502; found: 599.2525 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1R,2S)-2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (73d (R = MOM)) 
S S
OO O OH
2' 3'
1''
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                                                            73d (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.74 mL, 0.37 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (117 mg, 0.34 
mmol) in THF (3.4 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.22 mL, 
0.21 g, 0.74 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 
min at -50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde 
(±)-7d (128 mg, 0.67 mmol) in THF (0.8 mL, 0.8 M) was added via syringe. After 30 
min, the reaction was quenched by addition of saturated aq NH4Cl and the mixture was 
extracted with ethyl acetate. The organic layers were filtered through a short column 
layered with Na2SO4, SiO2, and Na2SO4 and the combined filtrates and washings were 
concentrated to give the crude product whose 1H NMR spectrum indicated the presence of 
an 8:1 mixture of 73d (R = MOM) and 72d (R = MOM), respectively. Fractionation of 
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the crude by FCC (25-35% ethyl acetate in hexane) afforded recovered aldehyde (±)-7d 
(50 mg, 59%), (±)-8ss (R = MOM) (25 mg, 21%), a 4:1 mixture of anti-aldol (±)-72d (R 
= MOM) and (±)-73d (R = MOM) (15 mg, 8%) and the titled compound (124 mg, 69%). 
IR (DRIFT) νmax 3455, 1700 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.05 (1H, br d, J = 9.5 Hz), 4.66 (1H, d, J = 6 Hz), 4.62 
(1H, d, J = 6 Hz), 4.50 (1H, dd, J = 4, 4.5 Hz), 4.07-3.92 (4H, m), 3.46 (1H, br s), 3.34 
(3H, s), 3.33-3.25 (4H, m), 3.12-3.08 (2H, m), 3.07-2.95 (3H, m), 2.89-2.72 (4H, m), 2.49 
(1H, br d, J = 13.5 Hz), 2.09-1.89 (4H, m), 1.83 (1H, br q, J = 7 Hz), 1.60 (1H, ddd, J = 
3.5, 12.5, 13.5 Hz), 1.05 (3H, d, J = 7 Hz), 1.03 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 210.4 (s), 108.8 (t), 98.4 (t), 78.0 (s), 72.1 (d), 69.1 (d), 
64.7 (t), 64.5 (t), 57.6 (d), 56.7 (q), 56.3 (d), 49.6 (d), 42.8 (d), 40.3 (t), 39.8 (t), 37.0 (t), 
36.1 (t), 33.0 (t), 32.1 (t), 28.2 (t), 26.7 (t), 11.5 (q), 10.8 (q). 
LRMS (ESI), m/z (relative intensity): 561 ([M+23]+, 40), 529 (10), 371 (100), 317 (5), 
     226 (6) . 
HRMS m/z calcd. for C23H38O6S4+Na: 561.1443; found: 561.1455 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1R,2S)-2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (73d (R = TES)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
TES
2'''
4'''5'''
1''''
2"
3"
SS
2''''
 
73d (R = TES) 
A solution of freshly prepared LDA (0.5 M in THF; 0.14 mL, 0.068 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = TES) (26 mg, 0.062 mmol) 
in THF (0.6 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (42 µL, 40 mg, 0.14 
mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -50 °C 
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(CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7d (23 mg, 
0.12 mmol) in THF (0.15 mL, 0.8 M) was added via syringe. After 16 h, the reaction was 
quenched by addition of saturated aq NH4Cl and the mixture was extracted with ethyl 
acetate. The organic layers were filtered through a short column layered with Na2SO4, 
SiO2, and Na2SO4 and the combined filtrate and washings were concentrated to give the 
crude product whose 1H NMR spectrum indicated the presence of a 1.3:1 mixture of 72d 
(R = TES) and 73d (R = TES), respectively. Fractionation of the crude by PTLC (10% 
ethyl acetate in hexane, multiple elutions) afforded recovered aldehyde (±)-7d (5 mg, 
22%), (±)-8ss (R = TES) (6 mg, 23%), anti aldol (±)-72d (R = TES) (11 mg, 29%), and 
the titled compound (9 mg, 24%). 
IR (DRIFT) νmax 3474, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.11 (1H, dd, J = 2, 10 Hz), 4.71 (1H, dd, J = 2.5, 6 Hz), 
4.05-3.81 (4H, m), 3.44 (1H, d, J = 2 Hz), 3.36-3.23 (4H, m), 3.16 (1H, ddd, J = 2, 4.5, 
13.5 Hz), 3.07-2.96 (2H, m), 2.94-2.85 (2H, m), 2.81-2.65 (4H, m), 2.549 (1H, br d, J = 
13.5 Hz), 2.05-1.94 (4H, m), 1.81 (1H, br q, J = 7 Hz), 1.61 (1H, ddd, J = 3.5, 12, 13.5 
Hz), 1.08 (3H, d, J = 7 Hz), 1.04 (3H, t, J = 7 Hz), 0.93 (9H, t, J = 8 Hz), 0.66-0.58 (6H, 
m). 
13C NMR (125 MHz, CDCl3) δ: 210.1 (s), 109.4 (s), 77.9 (s), 69.0 (d), 66.0 (d), 64.9 (t), 
64.5 (t), 59.1 (d), 56.2 (d), 50.1 (d), 42.8 (d), 40.5 (t), 40.0 (t), 37.0 (t), 36.5 (t), 32.2 (t), 
30.0 (t), 29.0 (t), 26.7 (t), 11.6 (q), 10.9 (q), 7.4 (q ×3), 5.4 (t ×3). 
LRMS (ESI), m/z (relative intensity): 631 ([M+23]+, 50), 468 (5), 441 (100). 
HRMS m/z calcd. for C27H48O5SiS4+Na: 631.2046; found: 631.2066 (ESI). 
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(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1R,2S)-2-(2-ethyl-1,3-dithian-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-
one (73e (R = MOM)) 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
MOM
2'''
4'''
5'''
1''''
2"
3"
SS
6"'
2""
  
73e (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.20 mL, 0.10 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (31 mg, 0.089 
mmol) in THF (0.9 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (60 µL, 57 
mg, 0.20 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min 
at -50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-
7e (37 mg, 0.18 mmol) in THF (0.23 mL, 0.8 M) was added via syringe. After 30 min, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The combined organic layers were filtered through a short column 
layered with Na2SO4, SiO2, and Na2SO4 and the combined filtrates and ethyl acetate 
washings were concentrated to give the crude product whose 1H NMR spectrum indicated 
the presence of a 2:1 mixture of anti-aldol 72e (R = MOM) and syn-aldol 73e (R = 
MOM), respectively. Fractionation of the crude by FCC (30% ethyl acetate in hexane) 
afforded recovered aldehyde (±)-7e (8 mg, 22%), (±)-8ss (R = MOM) (2 mg, 6%), anti-
aldol (±)-72e (R = MOM) (26 mg, 53%) and the titled compound (14 mg, 29%). A similar 
reaction conducted for 12 h gave a 1:1 mixture of 72e (R = MOM) and 73e (R = MOM) 
(80%). 
IR (DRIFT) νmax 3500, 1700 cm
-1
. 
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1
H NMR (500 MHz, CDCl3) δ: 5.08 (1H, dd, J = 3.5, 9 Hz), 4.68 (1H, d, J = 6 Hz), 4.63 
(1H, d, J = 6 Hz), 4.57 (1H, dd, J = 3.5, 6 Hz), 4.06-3.92 (4H, m), 3.35 (3H, s), 3.15-3.11 
(2H, m), 3.03-2.62 (10H, m), 2.70 (1H, d, J = 3.5 Hz), 2.49 (1H, br d, J = 13.5 Hz), 2.29 
(1H, dq, J = 7.5, 15 Hz), 2.08-1.85 (5H,), 1.79 (1H, br q, J = 7 Hz), 1.62-1.55 (1H, ddd, J 
= 3.5, 12, 13.5 Hz), 1.05 (3H, d, J = 7 Hz), 0.96 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 210.5 (s), 108.7 (s), 98.5 (t), 72.3 (d), 68.4 (d), 64.7 (t), 
64.5 (t), 59.6 (s), 57.9 (d), 56.7 (q), 55.9 (d), 49.3 (d), 41.5 (d), 36.1 (t), 32.8 (t), 31.8 (t), 
29.6 (t), 28.1 (t), 26.7 (t), 26.0 (t), 25.9 (t), 25.3 (t), 9.7 (q), 7.4 (q). 
HRMS m/z calcd. for C24H40O6S4+Na: 575.1599; found: 575.1614 (ESI). 
 
  
(3R,5R)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-5-
[(1R,2S)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (73f (R = MOM)) 
 
S S
OO O OH
2' 3'
1''
6
5
2
31'6'
7'9'
10'
O
MOM
2'''
4'''5'''
1''''
2"
3"
SS
 
 73f (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.20 mL, 0.10 mmol) at 0 
°C was added via syringe to a stirred solution of (+)-8ss (R = MOM) (32 mg, 0.092 
mmol) in THF (0.9 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.12 mL, 
0.11 g, 0.39 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 
min at -50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde 
(±)-7f (49 mg, 0.28 mmol) in THF (0.3 mL, 0.8 M) was added via syringe. After 4 h, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The organic layers were passed over a short column layered with 
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Na2SO4, SiO2, and Na2SO4 and concentrated to give the crude product whose 1H NMR 
spectrum indicated the presence of a 5:1 mixture of 73f (R = MOM) and 72f (R = MOM), 
respectively. Fractionation of the crude by PTLC (5% ethyl ether in CH2Cl2) afforded 
recovered aldehyde (±)-7f (16 mg, 33%), (+)-8ss (R = MOM) (4 mg, 13%), and an 
inseparable 5:1 mixture of (+)-73f (R = MOM) and (+)-72f (R = MOM), respectively (37 
mg, 77%) ([α]D +99; c 2.5, CHCl3).  
  
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy) 
methyl]-5-[(1R,2S)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-
thiopyran-4-one (73f (R = MOM)) 
S S
OO O OH
2' 3'
1''
6
5
2
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7'9'
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4'''5'''
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                                                             73f (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.20 mL, 0.10 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (31 mg, 0.089 
mmol) in THF (0.9 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.12 mL, 
0.11 g, 0.39 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 
min at -50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde 
(±)-7f (32 mg, 0.18 mmol) in THF (0.22 mL, 0.8 M) was added via syringe. After 2 h, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The organic layers were passed over a short column layered with 
Na2SO4, SiO2, and Na2SO4 and concentrated to give the crude product whose 1H NMR 
spectrum indicated the presence of a 7:1 mixture of 73f (R = MOM) and 72f (R = MOM), 
respectively. Fractionation of the crude by PTLC (5% ethyl ether in CH2Cl2) afforded 
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recovered aldehyde (±)-7f (16 mg, 50%), (±)-8ss (R = MOM) (4 mg, 13%), and an 
inseparable 7:1 mixture of (±)-73f (R = MOM) and (±)-72f (R = MOM) respectively 
compound (36 mg, 77%). 
IR (DRIFT) νmax 3458, 1700 cm
-1
. 
1
H NMR (500 MHz, C6D6) δ: 5.25 (1H, dd, J = 2, 9 Hz), 4.72-4.69 (2H, m), 4.63 (1H, d, 
J = 6 Hz), 3.52-3.424 (4H, m), 3.23-3.12 (2H, m), 3.16 (3H, s), 3.12-2.83 (6H, m), 2.82-
2.64 (6H, m), 2.26-2.21 (1H, m), 2.17 (1H, ddd, J = 4, 4, 10.5 Hz), 2.02 (1H, br q, J = 7 
Hz), 1.84 (3H, s), 1.69 (1H, ddd, J = 3, 4.5, 13.5 Hz), 1.55 (1H, ddd, J = 3.5, 12, 15.5 
Hz), 1.25 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, C6D6) δ: 209.6 (s), 109.2 (s), 98.5 (t), 72.6 (s), 72.5 (d), 69.7 (t), 
64.5 (t), 64.3 (t), 58.1 (d), 57.0 (d), 56.2 (q), 50.1 (d), 46.5 (d), 40.1 (t), 39.7 (t), 36.5 (t), 
                   33.1 (q), 32.6 (t), 31.7 (t), 28.8 (t), 26.9 (t), 11.5 (q) . 
HRMS m/z calcd. for C22H36O6S4+Na: 547.1286; found: 547.1272 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-
[(1R,2S)-2-(2-methyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-
4-one (73f (R = TES)) 
S S
OO O OH
2' 3'
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                                                             73f (R = TES) 
A solution of freshly prepared LDA (0.5 M in THF; 0.22 mL, 0.11 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = TES) (43 mg, 0.10 mmol) in 
THF (1 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (66 µL, 63 mg, 0.22 
mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min at -50°C 
(CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-7f (35 mg, 
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0.2 mmol) in THF (0.25 mL, 0.8 M) was added via syringe. After 3 h, the reaction was 
quenched by addition of saturated aq NH4Cl and the mixture was extracted with ethyl 
acetate (80 mL). The organic layers were filtered through a short column layered with 
Na2SO4, SiO2, and Na2SO4 and the combined filtrates were concentrated to give the crude 
product whose 1H NMR spectrum indicated the presence of a 3:1 mixture of anti aldol 72f 
(R = TES) and syn aldol 73f (R = TES), respectively. Fractionation of the crude by PTLC 
(10% ethyl acetate in hexane, multiple elution) afforded recovered aldehyde (±)-7f (10 
mg, 29%), (±)-8ss (R = TES) (6 mg, 14%), anti aldol (±)-72f (R = TES) (26 mg, 44%), a 
3:1 mixture of 72f (R = TES) and 73f (R = TES), respectively (8 mg, 14%), and the titled 
compound (10 mg, 17%). 
IR (DRIFT) νmax 3453, 1699 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.13 (1H, dd, J = 3, 9.5 Hz), 4.68 (1H, dd, J = 2, 6.5 Hz), 
4.05-3.79 (4H, m), 3.39-3.31 (4H, m), 3.18 (1H, ddd, J = 3, 3.5, 14 Hz), 3.12 (1H, d, J = 3 
Hz), 3.04 (1H, dd, J = 10.5, 13 Hz), 2.99 (1H, dd, J = 3.5, 14 Hz), 2.95-2.84 (2H, m), 
2.82-2.68 (2H, m), 2.49 (1H, ddd, J = 3.5, 3.5, 13.5 Hz), 2.05-1.99 (2H, m), 1.82 (3H, s), 
1.75 (1H, q, J = 6.5 Hz), 1.64 (1H, ddd, J = 3.5, 12, 13.5 Hz), 1.15 (3H, d, J = 7 Hz), 0.93 
(9H, t, J = 8 Hz), 0.67-0.57 (6H, m). 
13C NMR (125 MHz, CDCl3) δ: 210.1 (s), 109.6 (s), 72.1 (s), 69.3 (d), 65.9 (d), 64.9 (t), 
64.5 (t), 59.3 (d), 56.5 (d), 50.3 (d), 45.5 (d), 40.5 (t), 40.0 (t), 36.3 (t), 33.7 (q), 32.3 (t), 
30.0 (t), 29.1 (t), 26.7 (t), 11.4 (q), 7.3 (q ×3), 5.4 (t ×3). 
HRMS m/z calcd. for C26H46O5SiS4+Na: 617.1889; found: 617.1913 (ESI). 
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(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-
5-[(1S,2S)-2-(2-methyl-1,3-dioxolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-
thiopyran-4-one (73g (R = MOM)) 
S S
OO O OH
2' 3'
1''
6
5
2
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7'9'
10'
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                                                            73g (R = MOM) 
A solution of freshly prepared LDA (0.5 M in THF; 0.15 mL, 0.075 mmol) at 0 
°C was added via syringe to a stirred solution of (±)-8ss (R = MOM) (24 mg, 0.069 
mmol) in THF (0.7 mL, 0.1 M) at -78 °C under Ar. After 15 min, Ti(OiPr)4 (0.091 mL, 85 
mg, 0.30 mmol) was added. The reaction mixture was stirred for 10 min at -78 °C, 30 min 
at -50 °C (CH3CN/dry ice bath), and finally 5 min at -78 °C. A solution of aldehyde (±)-
7g (20 mg, 0.14 mmol) in THF (0.2 mL, 0.8 M) was added via syringe. After 1 h, the 
reaction was quenched by addition of saturated aq NH4Cl and the mixture was extracted 
with ethyl acetate. The organic layers were passed over a short column layered with 
Na2SO4, SiO2, and Na2SO4 and concentrated to give the crude product whose 1H NMR 
spectrum indicated the presence of a 3:1 mixture of 73g (R = MOM) and 72g (R = 
MOM), respectively. Fractionation of the crude by FCC (30% ethyl acetate in hexane) 
afforded recovered aldehyde (±)-7g (3 mg, 15%), (±)-8ss (R = MOM) (1 mg, 4%), anti 
aldol (±)-72g (R = MOM) (6 mg, 18%) and the titled compound (18 mg, 53%). 
IR (DRIFT) νmax 3513, 1701 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70-4.62 (3H, m), 4.47 (1H, dd, J = 4, 5 Hz), 4.07-3.92 
(8H, m), 3.35 (3H, s), 3.15 (1H, dd, J = 4, 13.5 Hz), 3.08-3.01 (3H, m), 2.99-2.89 (3H, 
m), 2.87-2.72 (3H, m), 2.49 (1H, br d, J = 13.5 Hz), 2.07 (1H, ddd, J = 3, 4, 14 Hz), 1.95 
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(1H, ddd, J = 3.5, 4, 10.5 Hz), 1.69 (1H, br q, J = 7 Hz), 1.63 (1H, ddd, J = 3.5, 13, 14 
Hz), 1.34 (3H, s), 0.99 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 210.9 (s), 112.7 (s), 108.9 (s), 98.6 (t), 72.4 (d), 67.8 (d), 
65.1 (t), 64.65 (t), 64.60 (t), 64.5 (t), 57.8 (d), 56.7 (q), 55.4 (d), 49.4 (d), 42.7 (d), 36.1 
(t), 32.8 (t), 32.1 (t), 28.2 (t), 26.8 (t), 22.3 (q), 7.8 (q). 
HRMS m/z calcd. for C22H36O8S2+Na: 515.1743; found: 515.1763 (ESI). 
 
Methyl 1,4,8-Trithiaspiro[4.5]decane-6-carboxylate (77) 
S
OMe
OSS
7'
2' 3'
9'
10' 1
5'
6'
 
                                                                    77 
A solution of beta-ketoester 75 (7.3 g, 42 mmol), 1,2-ethanedithiol (4.2 mL, 
4.7g, 50 mmol), and p-TsOH.H2O (1.6g, 8.4 mmol) in  50mL benzene was heated under 
reflux with continous removal of water (0.8 mL) with a Dean-Stark trap. After the 
reaction was complete via TLC (overnight, 20 hours), the reaction mixture was cooled 
and transferred to a separatory funnel with the aid of ether (150mL). The organic phase 
was washed sequentially with saturated NaHCO3 (2 x 100 mL), water (1 x 100 mL) and 
brine (1 x 100 mL) then dried over Na2SO4 and concentrated. The crude product was 
purified  by column with 50% ether in hexane gives pure product  (9.4 g, 90%). 
IR (DRIFT) νmax 1730 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 3.73 (3H, s), 3.30-3.15 (6H, m), 3.02 (1H, ap ddd, J = 
1.5,4.5,14 Hz), 2.91-2.84 (2H, m), 2.65-2.59 (1H, m), 2.21-2.16 (1H, m). 
13C NMR (125 MHz, CDCl3) δ: 171.7 (s), 68.2 (s), 54.3 (d), 52.1 (q), 40.4 (t), 39.4 (t), 
38.6 (t), 31.7 (t), 28.4 (t). 
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LRMS (EI), m/z (relative intensity): 250 ([M]+, 69), 189 (19), 157 (38), 136 (100), 118 
(25), 85 (22), 71 (48), 59 (84). 
HRMS m/z calcd. for C9H14O2S3: 250.0156; found: 250.0149 (EI). 
 
1,4,8-Trithiaspiro[4.5]decan-6-ylmethanol (79) 
S
OH
SS
7'
2' 3'
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79 
A solution of ester 77 (3.03 g, 12.1 mmol) in THF (4 mL plus 2× 2 mL rinses) 
was added via syringe to a stirred suspension of LiAlH4 (0.35 g, 9.1 mmol) in THF (10 
mL) at 0 °C under Ar. The ice bath was removed and, after 4 h, the reaction was complete 
by TLC. The mixture was cooled to 0 °C and water (0.4 mL) (CAUTION: H2 evolution), 
15% (w/v) NaOH (0.4 mL), and water (1.2 mL) were added sequentially with vigorous 
stirring. The ice bath was removed and the grayish suspension turned white over 1 h. The 
mixture was filtered through a short pad of Na2SO4 and Celite®, washing with ethyl 
acetate. The combined filtrate and washings were concentrated to give the crude 
compound that was fractionated by FCC (20% ethyl acetate in hexane) to give the titled 
compound as a pale yellow oil (2.5 g, 93%). 
IR (DRIFT) νmax 3396 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.08 (1H, dd, J = 4.5, 11.5 Hz), 3.86 (1H, dd, J = 6, 11.5 
Hz), 3.33-3.23 (4H, m), 2.93 (1H, br d, J = 14 Hz), 2.84 (1H, ddd, J = 2.5, 9.5, 13.5 Hz), 
2.70-2.64 (2H, m), 2.38 (1H, ddd, J = 3, 6.5, 14 Hz), 2.29-2.22 (2H, m), 2.22 (1H, br s). 
13C NMR (125 MHz, CDCl3) δ: 71.4 (s), 64.9 (t), 50.9 (d), 44.9 (br t), 39.39 (t), 39.10 (t), 
31.2 (t), 28.0 (t). 
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LRMS (EI), m/z (relative intensity): 222 ([M]+, 100), 194 (10), 164 (60), 136 (96), 99 
(32), 71 (30). 
HRMS m/z calcd. for C8H14OS3: 222.0207; found: 222.0207 (EI). 
 
Ethyl 2-(2-Ethyl-1,3-dioxolan-2-yl)propanoate (82) 
OO
O
O
2 11''
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                                                                    82 
A stirred solution of beta-ketoester 81 (12.0 g, 76 mmol), ethylene glycol (5.5 
mL, 6.1 g, 99 mmol), and p-TsOH·H2O (0.70 g, 3.8 mmol) in benzene (38 mL) was 
heated under reflux with removal of water via a Dean-Stark trap. After 14 h (reaction was 
completed by TLC analysis; 1.4 mL H2O collected), the mixture was diluted with ethyl 
acetate (200 mL) and washed sequentially with saturated NaHCO3, water and brine, dried 
over Na2SO4, concentrated, and fractionated by FCC (30% ethyl acetate in hexane) to 
give the titled compound as a colorless oil (12.1 g, 79%). 
IR (DRIFT) νmax 1736 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.19-4.11 (2H, m), 4.03-3.95 (4H, m), 2.83 (1H, q, J = 7 
Hz), 1.83 (1H, dq, J = 14.5, 7.5 Hz), 1.74 (1H, dq, J = 14.5, 7.5 Hz), 1.26 (3H, t, J = 7 
Hz), 1.19 (3H, d, J = 7 Hz), 0.90 (3H, t, J = 7.5 Hz). 
13
C NMR (500 MHz, CDCl3) δ: 173.7 (s), 111.9 (s), 65.9 (t), 65.8 (t), 60.6 (t), 47.0 (d), 
28.2 (t), 14.4 (q), 12.8 (q), 7.5 (q).                         . 
HRMS m/z calcd. for C10H18O4+H: 203.1283; found: 203.1288 (CI, NH3).  
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Ethyl 2-(2-Ethyl-1,3-dithian-2-yl)propanoate (84) 
SS
O
O
1
2
2'
4'
5'
6'
1''
2''
 
                                                                    84 
F3B·OEt2 (6.2 mL, 6.9 g, 49 mmol) was added to a stirred solution of beta-
ketoester 81 (7.0 g, 45 mmol) and 1,2-dithioethane (4.8 mL, 5.4 g, 47 mmol) in CH2Cl2 
(64 mL) at room temperature under Ar. After 30 min (reaction complete by TLC 
analysis), the mixture was diluted with diethyl ether (300 mL) and sat. NaHCO3  (200 
mL) was added with vigorous stirring (Caution: effervesence). After 30 min, the organic 
layer was washed sequentially with water and brine, dried over Na2SO4, concentrated and 
fractionated by FCC (15% ethyl acetate in hexane) to give the titled compound as a pale 
yellow oil (9.5 g, 86%). 
IR (DRIFT) νmax 1734 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.22.4.09 (2H, m), 3.40 (1H, q, J = 7 Hz), 3.12 (1H, ddd, 
J = 3, 11.5, 14.5 Hz), 2.93 (1H, ddd, J = 3, 11.5, 14.5 Hz), 2.71-2.66 (2H, m), 2.19 (1H, 
dq, J = 7.5, 15 Hz), 2.05-1.99 (1H, m), 1.89-1.78 (2H, m), 1.31 (3H, d, J = 7 Hz), 1.27 
(3H, t, J = 7 Hz), 1.10 (3H, t, J = 7.5 Hz). 
13
C NMR (125 MHz, CDCl3) δ: 173.5 (s), 60.6 (t), 55.6 (s), 46.3 (d), 27.9 (t), 26.2 (t), 
26.1 (t), 24.8 (t), 14.4 (q), 13.7 (q), 9.4 (q). 
LRMS (EI), m/z (relative intensity): 248 ([M]+, 20), 219 (13), 147 (100), 128 (20), 100 
(7), 68 (10). 
HRMS m/z calcd. for C11H20O2S2: 248.0905; found: 248.0904 (EI). 
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2-(2-Ethyl-1,3-dioxolan-2-yl)propan-1-ol (85) 
OO
OH
2 11''
2''
4' 5'
2'
 
                                                                      85 
A solution of ester 82 (3.2 g, 15.8 mmol) in THF (6 mL plus 2× 4 mL rinses) 
was added via syringe to a stirred suspension of LiAlH4 (0.66 g, 17.4 mmol) in THF (10 
mL) at 0 °C under Ar. The ice bath was removed and, after 1 h (the reaction was complete 
by TLC analysis), the mixture was cooled to 0 °C and water (0.7 mL) (CAUTION: H2 
evolution), 15% (w/v) NaOH (0.7 mL), and water (2.1 mL) were added sequentially with 
vigorous stirring. The ice bath was removed and the grayish suspension turned white over 
1 h. The mixture was filtered through a short pad of Na2SO4 and Celite®, washing with 
ethyl acetate. The combined filtrate and washings were concentrated and fractionated by 
FCC (50% ethyl acetate in hexane) to give the titled compound as a pale yellow oil (2.4 g, 
96%). 
IR (DRIFT) νmax 3440 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 3.98-3.95 (4H, m), 3.64 (1H, dd, J = 8, 11 Hz), 3.52 (1H, 
dd, J = 4, 11 Hz), 2.91 (1H, br s), 2.06 (1H, ddq, J = 4, 8, 7 Hz), 1.66 (2H, ap q, J = 7.5 
Hz), 0.93 (3H, d, J = 7 Hz), 0.89 (3H, t, J = 7.5 Hz). 
13
C NMR (125 MHz, CDCl3) δ: 114.7 (s), 65.3 (t), 65.2 (t), 65.0 (t), 40.6 (d), 26.7 (t), 
12.5 (q), 7.6 (q). 
HRMS m/z calcd. for C8H16O3+H: 161.1177; found: 161.1172 (CI, NH3).  
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2-(2-Ethyl-1,3-dithian-2-yl)propan-1-ol (87) 
SS
OH12
2'
4'
5'
6'
1''
2''
 
 87 
A solution of ester 84 (5.5 g, 22 mmol) in THF (20 mL + 2× 10 mL rinses) was 
added via syringe to a stirred suspension of LiAlH4 (1.5 g, 38.5 mmol) in THF (30 mL) at 
0 °C under Ar. The ice bath was removed and, after 9 h (reaction complete by TLC 
analysis), the mixture was cooled to 0 °C and water (1.5 ml) (Caution: hydrogen 
evolution), 15% (w/v) aq NaOH (1.5 ml), and water (4.5 ml) were added sequentially. 
The ice bath was removed and the greyish suspension turned white over 1 h. The mixture 
was filtered through a short pad of Na2SO4 and Celite® and the combined filtrate and 
ethyl acetate washings were concentrated and fractionated by FCC (20 % ethyl acetate in 
hexane) to give the titled compound (4.0 g, 89%). 
IR (DRIFT) νmax 3419 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 3.96 (1H, ddd, J = 5.5, 6,11.5 Hz), 3.73 (1H, ddd, J = 5.5, 
6.5,11.5 Hz), 2.89-  2.72 (4H, m) , 2.40 (1H, dd, J = 6, 6.5 Hz), 2.25-2/17 (1H, m), 2.11 
(1H, dq, J = 7.5, 15 Hz), 1.97-1.87 (3H, m), 1.11 (3H, d, J = 7 Hz), 1.03 (3H, t, J = 7.5 
Hz). 
13C NMR (125 MHz, CDCl3) δ: 65.5 (t), 57.8 (s), 41.1 (d), 28.8 (t), 25.9 (t), 25.8 (t), 25.3 
(t), 12.8 (q), 9.4 (q). 
LRMS (EI), m/z (relative intensity): 206 ([M]+, 13), 177 (10), 147 (100), 99 (10), 73 (17). 
HRMS m/z calcd. for C9H18OS2: 206.0790; found: 206.0792 (EI). 
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Ethyl 2-(2-Methyl-1,3-dithiolan-2-yl)propanoate (89) 
SS
O
O
2 11''
4' 5'
2'
 
                                                                   89 
F3B·OEt2 (2.0 mL, 2.3 g, 16 mmol) was added to a stirred solution of Ethyl 2-
methylacetoacetate 88 (2.10 g, 14.6 mmol) and 1,2-ethane dithiol (1.3 mL, 1.4 g, 15 
mmol) in CH2Cl2 (21 mL) at room temperature under Ar. After 2 h (reaction complete by 
TLC analysis), the mixture was diluted with ether (200 mL) and saturated NaHCO3 (150 
mL) was added with vigorous stirring (Caution: effervesence). After 30 min, the organic 
layer was washed with saturated sequentially with water and brine, dried over Na2SO4, 
concentrated and fractionated by FCC (15% ethyl acetate in hexane) to give the titled 
compound as a pale yellow oil (3.1 g, 97%). 
IR (DRIFT) νmax 1731 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.15 (2H, ap q, J = 7 Hz), 3.34-3.22 (4H, m), 2.97 (1H, q, 
J = 7 Hz), 1.85 (3H, s), 1.38 (3H, d, J = 7 Hz), 1.26 (3H, t, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 174.1 (s), 68.0 (s), 60.7 (t), 52.5 (d), 40.1 (t), 39.9 (t), 
29.5 (q), 16.1 (q), 14.4 (q). 
LRMS (EI), m/z (relative intensity): 220 ([M]+, 59), 205 (9), 175 (10), 121 (82), 120 (31), 
85 (17), 71 (25), 59 (100). 
HRMS m/z calcd. for C9H16O2S2: 220.0592; found: 220.0595 (EI). 
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Ethyl 2-(2-Methyl-1,3-dioxolan-2-yl)propanoate (90) 
 
OO
O
O
2 11''
4' 5'
2'
 
                                                                   90 
A stirred solution of ethyl 2-methylacetoacetate 88 (1.80 g, 12.5 mmol), ethylene 
glycol (1.4 mL, 1.6 g, 25 mmol), and p-TsOH·H2O (0.12 g, 0.63 mmol) in benzene (63 
mL) was heated under reflux with continuous removal of water with a Dean-Stark trap. 
After 12 h (the reaction was complete by TLC analysis; 0.2 mL H2O collected), the 
mixture was diluted with ethyl acetate (200 mL), washed sequentially with saturated 
NaHCO3, water and brine, dried over Na2SO4, concentrated, and fractionated by FCC 
(30% ethyl acetate in hexane) to give the titled compound (2.30 g, 98%). 
IR (DRIFT) νmax 1734 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.15 (2H, q, J = 7 Hz), 4.02-3.89 (4H, m), 2.75 (1H, q, J 
= 7 Hz), 1.40 (3H, s), 1.26 (3H , t, J = 7 Hz), 1.21 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 173.4 (s), 109.9 (s), 65.0 (t), 65.0 (t), 60.5 (t), 48.1 (d), 
21.5 (q), 14.3 (q), 13.0 (q). 
LRMS (EI), m/z (relative intensity): 173 ([M-15]+, 6), 87 (100). 
HRMS m/z calcd. for C9H16O4+H: 189.1126; found: 189.1125 (CI, NH3).  
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2-(2-Methyl-1,3-dithiolan-2-yl)propan-1-ol (91) 
SS
OH
2 11''
4' 5'
2'
 
                                                                      91 
A solution of ester 89 (2.90 g, 13.2 mmol) in THF (6 mL plus 2 x 2 mL rinses) 
was added via syringe to a stirred suspension of LiAlH4 (0.55 g, 14 mmol) in THF (10 
mL) at 0 °C under Ar. The ice bath was removed and, after 1.5 h,(reaction was complete 
by TLC analysis), the mixture was cooled to 0 °C and water (0.6 mL) (CAUTION: H2 
evolution), 15% (w/v) NaOH (0.6 mL), and water (1.8 mL) were added sequentially with 
vigorous stirring. The ice bath was removed and the grayish suspension turned white over 
1 h. The mixture was filtered through a short pad of Na2SO4 and Celite®, washing with 
ethyl acetate. The combined filtrate and washings were concentrated to give the crude 
compound that was fractionated by FCC (20% ethyl acetate in hexane) to give the titled 
compound as a pale yellow oil (2.25 g, 96%). 
IR (DRIFT) νmax 3389 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 3.87 (1H, dd, J = 5.5, 11 Hz), 3.62 (1H, dd, J = 5.5, 11 
Hz), 3.35-3.26 (4H, m), 2.33 (1H, br s), 2.14 (1H, ddq, J = 5.5, 5.5, 7 Hz), 1.73 (3H, s), 
1.15 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 70.4 (s), 66.7 (t), 47.7 (d), 39.8 (t), 39.6 (t), 31.0 (q), 
16.0 (q). 
LRMS (EI), m/z (relative intensity): 178 ([M]+, 5), 133 (3), 119 (100), 59 (26). 
HRMS m/z calcd. for C7H14OS2: 178.0486; found: 178.0481 (EI). 
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2-(2-Methyl-1,3-dioxolan-2-yl)propan-1-ol (92) 
OO
OH
2 11''
4' 5'
2'
 
 92 
A solution of ester 90 (2.30 g, 12.2 mmol) in THF (30 mL + 2× 5 mL rinses) was 
added via syringe to a stirred suspension of LiAlH4 (0.550 g, 14.6 mmol) in THF (20 mL) 
at 0 °C under Ar. The ice bath was removed and, after 45 min (the reaction complete by 
TLC analysis), the reaction mixture was cooled to 0 °C and quenched by sequential 
addition of water (0.55 mL), 15% (w/v) NaOH (0.55 mL), and water (1.6 mL) with 
vigorous stirring. The ice bath was removed and the grayish suspension turned white over 
1 h. The mixture was filtered through a short pad of Na2SO4 and Celite® and the 
combined filtrate and ether washings filtrate were concentrated to give the titled 
compound (1.72 g, 97%). 
IR (DRIFT) νmax 3444 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 3.99-3.94 (4H, m), 3.66-3.61 (1H, ddd, J = 2, 7.5, 11.5 
Hz), 3.54-3.50 (1H, ddd, J = 4, 7.5, 11.5 Hz), 3.10-2.70 (1H, br dd, J = 2, 7.5 Hz), 2.0-
1.96 (1H, ddq, J = 4, 7.5, 7 Hz), 1.28 (3H, s), 0.94 (3H, d, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 112.7 (s), 65.0 (t), 64.6 (t), 64.4 (t), 42.8 (d), 20.4 (q), 
12.6 (q). 
LRMS (ESI), m/z (relative intensity): 169 ([M+23]+, 100), 147 (15), 117 (18). 
HRMS m/z calcd. for C7H14O3+Na: 169.0835; found: 169.0828 (ESI). 
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(3R,5R)-rel-3-[(R)-(6R)-1,4,8-Trithiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-(6S)-
1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (103) 
S S
SS O
S
SSOH
2' 3' 3'' 2''
10''
9''7''
6''1''
6
5
2
31'6'
7'9'
10'
OH
 
                                                                     103 
From known 72a (R = MOM): F3B·OEt2 (8 µL, 9 mg, 0.07 mmol) was added to 
a stirred solution of bisaldol 72a (R = MOM) (16 mg, 0.030 mmol) and 1,2-ethanedithiol 
(10 µL, 11 mg, 0.12 mmol) in CH2Cl2 (0.3 mL, 0.1 M) at room temperature under Ar. 
After 1 h (reaction complete by TLC analysis), the mixture was diluted with CH2Cl2 (50 
mL) and aq NaOH (10% w/v; 25 mL) was added with vigorous stirring. After 30 min, the 
organic layer was washed sequentially with water and brine, dried over Na2SO4, 
concentrated, and fractionated by FCC (40% ethyl acetate in hexane) to give the titled 
compound (11 mg, 65%). 
From unknown 72b (R = MOM): Treatment of the unknown 72b (R = MOM) 
(19 mg, 0.033 mmol) with F3B·OEt2 (8 µL, 9 mg, 0.07 mmol) and 1,2-ethanedithiol (11 
µL, 12 mg, 0.13 mmol) according to the above procedure gave the titled compound (11 
mg, 61%). 
IR (DRIFT) νmax 3454, 1705 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.09 (1H, br dd, J = 3, 9 Hz), 4.09 (1H, dbr d, J = 2, 9.5 
Hz), 3.48 (1H, d, J = 3 Hz), 3.47-3.22 (9H, m), 3.18 (1H, ddd, J = 4, 9, 9.5 Hz), 3.07-2.87 
(6H, m), 3.01 (1H, d), 2.84-2.66 (5H, m), 2.61-2.52 (2H, m), 2.52-2.44 (2H, m), 2.38-2.27 
(2H, m), 2.23 (1H, br dd, J = 3, 10 Hz), 2.09-2.03 (1H, m). 
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13C NMR (125 MHz, CDCl3) δ: 211.4 (s), 73.6 (s), 73.3 (s), 70.8 (d), 69.9 (d), 56.6 (d), 
55.8 (d), 51.5 (d), 49.1 (d), 47.4 (t), 46.8 (t), 39.9 (t), 39.6 (t), 39.3 (t), 39.2 (t), 34.6 (t), 
34.3 (t), 28.8 (t), 28.3 (t ×2), 28.1 (t). 
HRMS m/z calcd. for C21H32O3S7+Na: 579.0288; found: 579.0301 (ESI). 
 
(3R,5R)-rel-3,5-bis[(R)-(6R)-1,4,8-Trithiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (104) 
S S
SS O
S
SSOH
2' 3' 3'' 2''
10''
9''7''
6''1''
6
5
2
31'6'
7'9'
10'
OH
 
                                                                     104 
From known 73a (R = MOM): F3B·OEt2 (26 µL, 30 mg, 0.21 mmol) was added 
to a solution of bisaldol 73a (R = MOM) (51 mg, 0.095 mmol) and 1,2-ethanedithiol (32 
µL, 36 mg, 0.38 mmol) in CH2Cl2 (1 mL, 0.1 M) at room temperature under Ar. After 1 h 
(reaction complete by TLC analysis), the mixture was diluted with CH2Cl2 (50 mL) and 
aq NaOH (10% w/v; 25 mL) was added with vigorous stirring. After 30 min, the organic 
layer was washed sequentially with water and brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (40% ethyl acetate in hexane) to give the titled compound (36 mg, 
68%). 
From unknown 73b (R = MOM): Treatment of the unknown 73b (R = MOM)  
(19 mg, 0.033 mmol) with F3B·OEt2 (6 µL, 7 mg, 0.05 mmol) and 1,2-ethanedithiol (7 
µL, 8 mg, 0.8 mmol) according to the above procedure gave the titled compound (7 mg, 
58%). 
IR (DRIFT) νmax 3447, 1696 cm
-1
. 
121 
  
1
H NMR (500 MHz, CDCl3) δ: 5.12 (2H, br dd, J = 2, 9 Hz), 3.43 (2H, d, J = 2 Hz), 
3.42-3.24 (5H, m), 3.21-3.15 (1H, m), 3.07-2.94 (7H, m), 2.80-2.70 (4H, m), 2.59-2.53 
(2H, m), 2.46-2.40 (4H, m), 1.94 (2H, ap dd, J = 4.5, 9.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 211.2 (s), 73.7 (s ×2), 69.0 (d ×2), 56.6 (d ×2), 50.9 (d 
×2), 47.4 (t ×2), 39.6 (t ×2), 39.5 (t ×2), 34.4 (t ×2), 28.4 (t ×2), 28.3 (t ×2). 
         . 
HRMS m/z calcd. for C21H32O3S7+Na: 579.0288; found: 579.0304 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6S)-1,4,8-trithiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one 
(105) 
S S
OO O
S
SSOH
2' 3' 3'' 2''
10''
9''7''
6''1''
6
5
2
31'6'
7'9'
10'
OH
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From new 72b (R = TES): A solution of 30% aq HF (0.9 mL) was added to a 
stirred solution of 72b (R = TES) (9 mg, 0.014 mmol) in CH3CN (2 mL) at 0 °C. After 5 
min (reaction complete by TLC analysis), the mixture was diluted with ethyl acetate and 
washed sequentially with saturated aq NaHCO3 and brine, dried over Na2SO4, 
concentrated, and fractionated by PTLC (30% ethyl acetate in hexane, multiple elution) to 
give the titled compound (3 mg, 43%). 
From known 72b (R = MOM): TiCl4 (29 µL, 49 mg, 0.26 mmol) was added 
dropwise via syringe to a stirred solution of 72b (R = MOM) (29 mg, 0.051 mmol) in 
CH2Cl2 (2.6 mL, 0.02 M) at –78 °C under argon. After 5 min, a fine yellow slurry 
developed and thiophenol (52 µL, 56 mg, 0.51 mmol) was added dropwise to the mixture 
resulting in a red-orange fine slurry. After 2 h, MeOH (2 mL) was added (the mixture 
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became colorless) and the cooling bath was removed. Phosphate buffer (pH=7; 8 mL) was 
added and, after 3 min, the mixture was diluted with aq NaHCO3 and extracted with 
CH2Cl2. The combined organic extracts were dried over Na2SO4, concentrated, and 
fractionated by FCC (40 % ethyl acetate in hexane) to give recovered 72b (R = MOM)  
(17mg, 59%) and the titled compound (7mg, 26%). 
IR (DRIFT) νmax 3500, 1706 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.17 (1H, dd, J = 2.5, 9 Hz), 4.59-4.54 (1H, br d, J = 8.5 
Hz), 4.11-3.94 (4H, m), 3.46-3.20 (6H, m), 3.3.26 (1H, br s), 3.08-2.91 (4H, m), 2.87-
2.69 (7H, m), 2.60-2.46 (3H, m), 2.30 (1H, ddd, J = 3,11.5, 14 Hz), 2.21 (1H, ddd, J = 2, 
3, 10 Hz), 2.15 (1H, ddd, J = 2.5, 4.5, 13.5 Hz), 2.04 (1H, ap dd, J = 5, 8.5 Hz), 1.75 (1H, 
ddd, J = 3.5, 11, 13.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 211.3 (s), 110.3 (s), 73.2 (s), 70.8 (d), 67.5 (d), 64.8 (t), 
64.3 (t), 56.5 (d), 54.6 (d), 51.7 (d), 47.3 (t), 45.7 (d), 40 (t), 39.6 (t), 36.0 (t), 34.4 (t), 
34.2 (t), 28.7 (t), 28.3 (t), 26.7 (t), 26.3 (t). 
HRMS m/z calcd. for C21H32O5S5+Na: 547.0745; found: 547.0729 (ESI). 
 
(2S,3R,4R,6R,7S,8R)-rel-2,8-Bis(2-ethyl-1,3-dioxolan-2-yl)-7-hydroxy-3-
methoxymethoxy-4,6-dimethylnonan-5-one (106) 
O HOOO OOO
MOM
1
2
3
4
5 6 7
8
9
2' 2"
4"5"4' 5'
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From known 72a (R = MOM): A suspension of Raney Ni (W-2) (0.5 mL settled 
volume) in ethanol was added in one portion to a stirred solution of 72a (R = MOM)  (16 
mg, 0.030 mmol) in ethanol (3 mL, 0.01 M) and the reaction mixture was heated under 
reflux. After 30 min, the mixture was decanted and the solid suspended in ethanol and 
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heated under reflux with rapid stirring for several min. The above washing procedure was 
repeated with ethyl acetate and acetone. The supernatants were filtered through a pad of 
Celite® and the combined filtrates were concentrated and fractionated by PTLC (30% 
ethyl acetate in hexane) to give the titled compound (6 mg; ca. 90% pure). 
From unknown 72c (R = MOM): Treatment of bisaldol 72c (R = MOM)  (50 mg, 
0.099 mmol) with Raney Ni as described above gave the titled compound (24 mg, 55%). 
IR (DRIFT) νmax 3519, 1710 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70 (1H, d, J = 6.5 Hz), 4.59 (1H, d, J = 6.5 Hz), 4.03 
(1H, dd, J = 3.5, 4 Hz), 4.01-3.93 (9H, m), 3.35 (3H, s), 3.12-3.06 (2H, m), 2.97 (1H, dq, 
J = 7, 9.5 Hz), 2.05-1.98 (2H, m), 1.72 (2H, ap q, J = 7.5 Hz), 1.69 (2H, ap q, J = 7.5 Hz), 
1.10 (3H, d, J = 7 Hz), 0.97 (3H, d, J = 7 Hz), 0.95 (3H, d, J = 7 Hz), 0.94 (3H, d, J = 7 
Hz), 0.88 (6H, ap t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 217.3 (s), 114.9 (s), 113.8 (s), 97.0 (t), 76.4 (d), 74.3 (d), 
65.7 (t), 65.28 (t), 65.26 (t), 64.9 (t), 56.4 (q), 53.2 (d), 48.2 (d), 42.2 (d), 38.4 (q), 28.3 
(t), 26.9 (t), 13.2 (q), 11.3 (q), 10.7 (q), 8.4 (q), 7.7 (q), 6.6 (q). 
HRMS m/z calcd. for C23H42O8+Na: 469.2771; found: 469.2769 (ESI). 
 
(2S,3R,4R,6R,7R,8S)-rel-2,8-Bis(2-ethyl-1,3-dioxolan-2-yl)-7-hydroxy-3-
methoxymethoxy-4,6-dimethylnonan-5-one (107) 
 
O HOOO OOO
MOM
1
2
3
4
5 6 7
8
9
2' 2"
4"5"4' 5'
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From known 73a (R = MOM): A suspension of Raney Ni (W-2) (0.5 mL settled 
volume) in ethanol was added in one portion to a stirred solution of bisketal 73a (R = 
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MOM) (52 mg, 0.097 mmol) in ethanol (10 mL, 0.01 M) and the reaction mixture was 
heated under reflux. After 1 h, the mixture was decanted and the solid suspended in 
ethanol and heated under reflux with rapid stirring for several min. The above washing 
procedure was repeated with ethyl acetate and acetone. The supernatants were filtered 
through a pad of Celite® and the combined filtrates were concentrated and fractionated 
by PTLC (30% ethyl acetate in hexane) to give the titled compound (24 mg; ca. 85% 
purity). 
From unknown 73c (R = MOM): Treatment of bisaldol 73c (R = MOM)  (30 mg, 0.059 
mmol) with Raney Ni as described above gave the titled compound (11 mg, 42%). 
IR (DRIFT) νmax 3526, 1704 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.69 (1H, d, J = 6.5 Hz), 4.59 (1H, d, J = 6.5 Hz), 4.06-
4.03 (2H, m), 4.01-3.93 (8H, m), 3.35 (3H, s), 3.05 (1H, br s), 3.01-2.93 (2H, m), 1.91 
(1H, dq, J = 3, 7 Hz), 1.80 (1H, dq, J = 1.5, 7 Hz), 1.75-1.64 (4H, m), 1.21 (3H, d, J = 7 
Hz), 1.10 (3H, d, J = 7 Hz), 0.96 (3H, d, J = 7 Hz), 0.94 (3H, d, J = 7 Hz), 0.86 (3H, t, J = 
7.5 Hz), 0.85 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 216.1 (s), 114.7 (s), 113.6 (s), 97.6 (t), 76.4 (d), 72.0 (d), 
65.7 (t), 65.3 (t), 65.2 (t), 65.0 (t), 56.5 (q), 51.9 (d), 49.4 (d), 42.5 (d), 39.8 (d), 28.1 (t), 
27.1 (t), 14.1 (q), 12.3 (q), 10.4 (q), 8.1 (q), 7.7 (q), 7.6 (q). 
HRMS m/z calcd. for C23H42O8+Na: 469.2771; found: 469.2792 (ESI). 
 
(3R,5R)-rel-3-[(R)-(6R)-1,4,8-Trithiaspiro[4.5]dec-6-yl(hydroxy)methyl]-5-[(1S,2R)-
2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-one (108) 
S S
SS O SSOH
2' 3'
2'''
7''
6''1''
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From unknown 72d (R = MOM): F3B·OEt2 (9 µL, 10 mg, 0.07 mmol) was 
added to a solution of bisaldol 72d (R = MOM) (16 mg, 0.030 mmol) and 1,2-
ethanedithiol (10 µL, 11 mg, 0.12 mmol) in CH2Cl2 (0.3 mL, 0.1 M) at room temperature 
under Ar. After 1 h (reaction complete by TLC analysis), the mixture was diluted with 
CH2Cl2 (50 mL) and aq NaOH (10% w/v; 25 mL) was added with vigorous stirring. After 
30 min, the organic layer was washed sequentially with water and brine, dried over 
Na2SO4, concentrated, and fractionated by FCC (30% ethyl acetate in hexane) to give the 
titled compound (11 mg, 70%). 
From known 72c (R = MOM): Treatment of the known 72c (R = MOM) (21 mg, 0.041 
mmol) with F3B·OEt2 (11 µL, 13 mg, 0.09 mmol) and 1,2-ethanedithiol (13 µL, 15 mg, 
0.16 mmol) according to the above procedure gave the titled compound (12 mg, 55%). 
IR (DRIFT) νmax 3454, 1704 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.02 (1H, br dd, J = 3, 9 Hz), 4.97 (1H, br dd, J = 2.5, 9.5 
Hz), 3.52 (1H, d, J = 3 Hz), 3.40-3.19 (10H, m), 3.04 (1H, d, J = 2.5 Hz), 3.00 (1H, dd, J 
= 4, 13.5 Hz), 2.78-2.89 (2H, m), 2.86 (1H, ddd, J = 4.5, 5, 9.5 Hz), 2.80-2.67 (3H, m), 
2.56 (1H, br d, J = 13.5 Hz), 2.49 (1H, ddd, J = 2.5, 5, 14 Hz), 2.33 (2H, ddd, J = 3, 11, 
14 Hz), 2.22 (1H, dd, J = 4, 9.5 Hz), 2.10-1.99 (2H, m), 1.96 (1H, q, J = 7 Hz), 1.11 (3H, 
d, J = 7 Hz), 1.07 (3H, t, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 212.1 (s), 77.7 (s), 73.6 (s), 70.9 (d), 70.0 (d), 56.9 (d), 
55.8 (d), 49.0 (d), 46.6 (t), 44.1 (d), 40.5 (t), 40.0 (t), 39.4 (t), 39.2 (t), 36.4 (t), 34.7 (t), 
34.1 (t), 28.2 (t), 28.1 (t), 11.7 (q), 10.9 (q). 
         . 
HRMS m/z calcd. for C21H34O3S6+Na: 549.0724; found: 549.0720 (ESI). 
 
 
126 
  
(3R,5R)-rel-3-[(R)-(6R)-1,4,8-Trithiaspiro[4.5]dec-6-yl(hydroxy)methyl]-5-[(1R,2S)-
2-(2-ethyl-1,3-dithiolan-2-yl)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-one (109) 
S S
SS O SSOH
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From known 73c (R = MOM): F3B·OEt2 (8 µL, 9 mg, 0.06 mmol) was added to 
a solution of bisketal 73c (R = MOM) (14 mg, 0.028 mmol) and 1,2-ethanedithiol (9 µL, 
10 mg, 0.11 mmol) in CH2Cl2 (0.3 mL, 0.1 M) at room temperature under Ar. After 0.5 h 
(reaction complete by TLC analysis), the mixture was diluted with CH2Cl2 (50 mL) and 
aq NaOH (10% w/v; 25 mL) was added with vigorous stirring. After 30 min, the organic 
layer was washed sequentially with water and brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (25% ethyl acetate in hexane) to give the titled compound (8 mg, 
53%). 
From unknown 73d (R = MOM): Treatment of the bisaldol 73d (R = MOM) (12 
mg, 0.022 mmol) with F3B·OEt2 (6 µL, 7 mg, 0.05 mmol) and 1,2-ethanedithiol (7 µL, 8 
mg, 0.09 mmol) according to the above procedure gave the titled compound (8 mg, 67%).  
IR (DRIFT) νmax 3450, 1696 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 5.11 (1H, br d, J = 9.5 Hz), 5.04 (1H, dd, J = 2, 9 Hz), 
3.55 (1H, d, J = 2 Hz), 3.41-3.26 (9H, m), 3.22 (1H, dd, J = 4, 13.5 Hz), 3.13 (2H, ap d, J 
= 5 Hz), 3.10-3.05 (1H, ddd, J = 4.5, 8.5, 9 Hz), 3.0-2.92 (3H, m), 2.78-2.70 (2H, m), 
2.54 (1H, br d, J = 14 Hz), 2.46 (1H, ddd, J = 2.5, 4, 14 Hz), 2.27 (1H, ddd, J = 3, 12, 14 
Hz), 2.08-1.96 (3H, m), 1.78 (1H, q, J = 7 Hz), 1.082 (3H, d, J = 7 Hz), 1.079 (3H, t, J = 
7 Hz). 
127 
  
13C NMR (125 MHz, CDCl3) δ: 211.8 (s), 78.2 (s), 73.7 (s), 69.4 (d), 69.1 (d), 57.4 (d), 
56.4 (d), 50.6 (d), 47.6 (t), 43.6 (d), 40.5 (t), 40.1 (t), 39.4 (t), 39.3 (t), 37.0 (t), 34.4 (t), 
34.3 (t), 28.6 (t), 28.1 (t), 11.8 (q), 10.9 (q). 
HRMS m/z calcd. for C21H34O3S6+Na: 549.0724; found: 549.0741 (ESI). 
 
(2S,3R,4R,6R,7R,8S)-rel-2-(2-Ethyl-1,3-dioxolan-2-yl)-7-hydroxy-3-
methoxymethoxy-4,6,8-trimethylundecan-5-one (110) 
O HOOO O
MOM
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From unknown 72e (R = MOM): A suspension of Raney Ni (W-2) (0.5 mL 
settled volume) in ethanol was added in one portion to a stirred solution of 72e (R = 
MOM) (22 mg, 0.040 mmol) in ethanol (4 mL, 0.01 M) and the reaction mixture was 
heated under reflux. After 2 h, the mixture was decanted and the solid suspended in 
ethanol and heated under reflux with rapid stirring for several min. The above washing 
procedure was repeated with ethyl acetate and acetone. The supernatants were filtered 
through a pad of Celite® and the combined filtrates were concentrated and fractionated 
by PTLC (25% ethyl acetate in hexane) to give the titled compound (7 mg; ca. 85% pure). 
From known 72b (R = MOM): Treatment of bisaldol 72b (R = MOM) (51 mg, 
0.090 mmol) with Raney Ni as described above gave the titled compound (21 mg, 60%). 
IR (DRIFT) νmax 3504, 1707 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70 (1H, d, J = 6.5 Hz), 4.59 (1H, d, J = 6.5 Hz), 4.06 
(1H, ddd, J = 3, 5.5 Hz), 3.96 (4H, br s), 3.63 (1H, ddd, J = 3, 5.5, 8.5 Hz), 3.36 (3H, s), 
3.03 (2H, dq, J = 6, 7 Hz), 2.97 (1H, dq, J = 8.5, 7 Hz), 2.15 (1H, d, J = 5.5 Hz), 1.94 
(1H, dq, J = 3, 7 Hz), 1.76-1.65 (2H, m), 1.60-1.50 (1H, m), 1.40-1.20 (4H, m), 1.13 (3H, 
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d, J = 7 Hz), 1.04 (3H, d, J = 7 Hz), 0.95 (3H, d, J = 7 Hz), 0.89 (3H, t, J = 7 Hz), 0.87 
(3H, d, J = 7 Hz), 0.87 (3H, t, J = 7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 218.3 (s), 113.6 (s), 97.5 (t), 76.7 (d), 76.6 (d), 65.3 (t), 
65.2 (t), 56.5 (q), 52.0 (d), 48.4 (d), 42.3 (d), 36.6 (t), 34.5 (d), 27.1 (t), 20.6 (t), 14.5 (q), 
13.8 (q), 12.7 (q), 12.4 (q), 10.4 (q), 7.7 (q). 
HRMS m/z calcd. for C21H40O6+Na: 411.2722; found: 411.2714 (ESI). 
 
(3R,5R)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]-5-
[(1R,2S)-1-hydroxy-2-methylbutyl]tetrahydro-4H-thiopyran-4-one (113) 
S S
OO O OH
2' 3'
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A solution of (+)-8ss (R = MOM) (29 mg, 0.083 mmol) in CH2Cl2 (0.4 mL; 0.2 
M) was added dropwise via syringe over 5 min to a stirred solution of ClB(C6H11)2 (1 M 
in CH2Cl2; 0.17 mL, 0.17 mmol) and Et3N (24 µL, 17 mg, 0.17 mmol) in CH2Cl2 (0.4 
mL; 5 mL/mmol of 8ss) at -78 °C under Ar. After 2 h, a solution of aldehyde (+)-112 
(0.15 mL from a 1.1 M solution of aldehyde 112 in CH2Cl2; 15 mg, 0.17 mmol) was 
added slowly via syringe (ca. 5 min). After 23 h, the reaction was quenched by sequential 
addition of phosphate buffer (pH 7; 2 mL), MeOH (2 mL), and 30% aq H2O2 (1 mL). The 
mixture was stirred at 0 °C for 10 min and then was diluted with ice-water and saturated 
aq Na2SO3 (ca. 5 mL) and extracted with CH2Cl2. The combined organic layers were 
dried over Na2SO4 and concentrated to give the crude product whose 1H NMR spectrum 
indicated the presence of a 14:1 mixture of the titled compound and a side product, 
respectively, along with unreacted (+)-8ss (R = MOM). Fractionation of the crude by 
FCC (20-30% ethyl acetae in hexane) afforded side product (4 mg, 11%) recovered (+)-
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8ss (R = MOM) (2 mg, 7%) and the titled compound (28 mg, 78 %) ([α]D +82 ; c 1.1 , 
CHCl3).  
IR (DRIFT) νmax 3526, 1704 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.70 (1H, d, J = 6 Hz), 4.61 (1H, d, J = 6 Hz), 4.56 (1H, 
dd, J = 4.5, 6.5 Hz), 4.10-3.91 (4H, m), 4.03-3.90 (1H, ddd, J = 3, 5.5, 8 Hz), 3.36 (3H, 
s), 3.19 (1H, ddd, J = 1, 7.5, 13.5 Hz), 3.06-3.01 (1H, m, J = 4.5, 7, 7 Hz), 2.98-2.89 (3H, 
m), 2.84-2.64 (4H , m), 2.59 (1H, d, J = 5.5 Hz), 2.50 (1H, br d, J = 13.5 Hz), 2.07 (1H, 
ddd, J = 3, 4.5, 13.5 Hz), 2.03 (1H, ddd, J = 4, 4, 10.5 Hz), 1.65 (1H, ddd, J = 3.5, 12, 
13.5 Hz), 1.57-1.40 (2H, m), 1.38-1.29 (1H, m), 0.92 (3H, t, J = 7 Hz), 0.88 (3H, d, J = 
6.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 213.3 (s), 108.9 (s), 98.5 (t), 72.95 (t), 72.93 (d), 64.7 (t), 
64.5 (t), 58.3 (d), 56.8 (q), 53.8 (d), 49.0 (d), 36.3 (d), 36.1 (t), 31.4 (q), 30.3 (t), 28.2 (t), 
27.0 (t), 26.7 (t), 12.4 (q), 12.1 (q). 
HRMS m/z calcd. for C20H34O6S2+Na: 457.1689; found: 457.1697 (ESI). 
 
(2S,3R,4R,6R,7R,8S)-rel-2-(2-Ethyl-1,3-dioxolan-2-yl)-7-hydroxy-3-
methoxymethoxy-4,6,8-trimethyldecan-5-one (114) 
O HOOO O
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From known 113: A suspension of Raney Ni (W-2) (0.5 mL settled volume) in 
ethanol was added in one portion to a stirred solution of (+)-113 (25 mg, 0.058 mmol) in 
ethanol (6 mL, 0.01 M) and the reaction mixture was heated under reflux. After 2 h, the 
mixture was decanted and the solid suspended in ethanol and heated under reflux with 
rapid stirring for several min. The above washing procedure was repeated with ethyl 
acetate and acetone. The supernatants were filtered through a pad of Celite® and the 
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combined filtrates were concentrated and fractionated by PTLC (25% ethyl acetate in 
hexane) to give retro-aldol/elimination 115 (9 mg, 69%) and the titled compound (5 mg; 
23%). 
From unknown 72f (R = MOM): Treatment of bisldol (+)-72f (R = MOM) (32 
mg, 0.061 mmol) with Raney Ni as described above gave the titled compound (9 mg, 
39%) ([α]D -5; c 0.9, CHCl3).  
IR (DRIFT) νmax 3503, 1706 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ: 4.71 (1H, d, J = 6.5 Hz), 4.59 (1H, d, J = 6.5 Hz), 4.07 
(1H, dd, J = 3, 5.5 Hz), 3.96 (4H, ap s), 3.69-3.63 (1H, m), 3.37 (3H, s), 3.02 (1H, dq, J = 
5.5, 7 Hz), 2.97 (1H, dq, J = 8.5, 7 Hz), 2.14 (1H, d, J = 5.5 Hz), 1.96 (1H, dq, J = 3, 7 
Hz), 1.76-1.65 (2H, m), 1.49-1.38 (2H, m), 1.33-1.24 (1H, m), 1.14 (3H, d, J = 7 Hz), 
1.04 (3H, d, J = 7 Hz), 0.96 (3H, d, J = 7 Hz), 0.92 (3H, t, J = 7.5 Hz), 0.88 (3H, d, J = 7 
Hz), 0.87 (3H, t, J = 7 Hz). 
13C NMR (125 MHz, CDCl3) δ: 218.3 (s), 113.6 (s), 97.6 (t), 76.6 (t), 76.4 (d), 65.3 (t), 
65.2 (t), 56.5 (q), 52.0 (d), 48.5 (d), 42.3 (d), 36.7 (q), 27.1 (t ×2), 13.8 (q), 12.5 (q), 12.4 
(q), 12.1 (q), 10.4 (q), 7.7 (q). 
HRMS m/z calcd. for C20H38O6+Na: 397.2560; found: 397.2567 (ESI). 
 
 (E)-6-(2-Ethyl-1,3-dioxolan-2-yl)-4-methylhept-4-en-3-one (115) 
OO O2'
4'5'
1
23
4
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6
7
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2''
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see experimental procedure for compound 114.  
1
H NMR (500 MHz, CDCl3) δ: 6.57 (1H, d, J = 10 Hz), 4.0-3.85 (4H, m), 2.95 (1H, dq, J 
= 7, 10 Hz), 2.69 (2H, ap , J = 7.5 Hz), 1.80 (3H, s), 1.67 (1H, dq, J = 14.5, 7.5 Hz), 1.58 
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(1H, dq, J = 14.5, 7.5 Hz), 1.09 (3H, t, J = 7.5 Hz), 1.02 (3H, d, J = 7 Hz), 0.88 (3H, t, J = 
7.5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 203.0 (s), 143.1 (d), 137.1 (s), 113.3 (s), 66.10 (t), 66.04 
(t), 40.8 (d), 30.7 (t), 29.5 (t), 14.5 (q), 11.8 (q), 9.0 (q), 7.9 (q). 
HRMS (EI), m/z (relative intensity): 226 ([M]+, 30), 197 (10), 101 (100). 
HRMS m/z calcd. for C13H22O3: 226.1569; found: 226.1571 (EI). 
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